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GENERAL INTRODUCTION
The World Health Organisation (WHO) defines preterm birth as birth before 37 completed
weeks of gestation or birth before 259 days after the first day of the last normal menstrual
period and adjusted if necessary by ultrasound estimates of gestation 1. However, several
studies have defined preterm birth as delivery of a low (<2500 grams) birth weight infant 2, 3.
Preterm birth is the most important problem in obstetrics and perinatology 4. It is estimated
that each year 13 million infants world wide are born prematurely. The incidence is reported to
be 5-10% from country to country. Despite numerous intervention strategies to reduce preterm
birth this incidence has remained stable throughout the years 1, 5. Prematurity is the single most
important cause of neonatal mortality and morbidity, where 70-80% of neonatal mortality is
due to preterm delivery and 80 percent of neonatal morbidity occurs in the premature born
infant 5-11.
Studies on preterm birth have assessed a long list of risk factors such as demographic
characteristics, reproductive history, psycho-social factors, behaviour status, micro-nutrient
intake, anaemia, utero-placental-fetal membrane pathology, underlying medical conditions,
cervical length and vaginal infections 2, 12. Next to the identification of risk factors for preterm
birth, attempts have been made to classify preterm birth into aetiologically homogeneous
entities. Preterm birth has been divided into; delivery indicated due to maternal or fetal
complications; delivery in which the initial event was spontaneous labour; or delivery in which
the initial event was a spontaneous rupture of membranes 13. However, since it was recognised
that spontaneous labour and preterm premature rupture of the membranes are likely to be the
results of similar processes only a dichotomy has been drawn between spontaneous and
indicated preterm birth 14-17.
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It is generally recognised that abnormal genital tract microflora is associated with spontaneous
preterm birth based on the following observations 17. The yield of micro-organisms after
amniocentesis was 16 % in women with preterm labour or without prolonged rupture of the
membranes (PROM) 18. Micro-organisms found in the lower genital tract, especially those
related to bacterial vaginosis are associated with increased risk for preterm labour 19-24;
however no single causative organism has been identified 3. A strong relationship has been
demonstrated between histological evidence of infection of the amniotic cavity and preterm
delivery 25. Neonates born prematurely are more at risk for early neonatal sepsis and mothers
show an increased risk for endometritis after preterm birth 17, 26. Antibiotic therapy in order to
prevent preterm birth has shown successful in reducing preterm birth in women at increased
risk for prematurity and bacterial vaginosis 27, 28. In cases of preterm PROM antibiotic therapy
has shown to be effective in postponing delivery and preventing early onset infection in the
neonate 29-32.
The relationship between abnormal genital tract microflora and inflammation and infection of
the genital tract with preterm birth is the focus of interest of this thesis.
11 \ 155
AIM OF THESIS
The aim of this thesis is to answer the following questions regarding the relationship between
preterm birth and inflammation and infection of the lower genital tract:
1. Can the incidence of preterm birth be reduced in a group of pregnant women at high risk for
preterm delivery by prophylactic administration of clindamycin vaginal creme during
pregnancy?
2. To what extend does change vaginal flora by prophylactic administration of clindamycin
vaginal creme during pregnancy?
3. Is an expectant management protocol aimed at prolongation of pregnancy in cases of
preterm prolonged rupture of the membranes beneficial to the fetus?
4. How accurate is the clinical diagnosis intra-amniotic infection?
5. Which perinatal events are risk factors for the development of severe cranial ultrasound
abnormalities in the preterm neonate?
6. Which perinatal events are risk factors for an adverse neurodevelopmental outcome in the
preterm born neonate?
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OUTLINE OF THE THESIS
In Chapter 1 an overview is given of the mechanisms resulting in term labour and delivery and
along with a survey of the possible mechanisms resulting in preterm labour and delivery. The
differences and similarities between mechanisms leading to term and preterm labour are
discussed. This chapter ends with a synopsis of the possible role of inflammation and infection
originating from the lower genital tract and preterm labour.
Next Chapter 2 presents the results of a randomised multicentre study in which the hypothesis
was tested that clindamycin 2 % vaginal creme given prophylacticly twice during pregnancy to
women at high risk for a spontaneous preterm birth could reduce the incidence of preterm
delivery. The high-risk group consisted of women with a spontaneous preterm birth in the
preceding pregnancy having an estimated recurrence risk of 25%.
In Chapter 3 the results of a study are presented in which the influence of clindamycin 2%
vaginal creme on the vaginal flora was analysed. This study was part of the multicentre study
as described in Chapter 2.
Chapter 4 describes the outcome of neonates after an expectant management during prolonged
rupture of the membranes in the preterm period. The hypothetical neonatal survival rate at the
time of rupture of the membranes was compared to the actual survival rate after this expectant
management protocol to gain insight on whether this type of management was beneficial with
respect to perinatal mortality.
Then in Chapter 5 the accuracy of the clinical diagnosis of intra-amniotic infection in cases
with prolonged rupture of membranes in the preterm period was evaluated. The clinical
antepartum diagnosis of intra-amniotic infection was compared to histological, microbiological
and clinical signs of infection in the neonate and placenta.
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Chapter 6 presents the results of a study in which the possible influences of a large number of
perinatal events on the development of severe cranial ultrasound abnormalities were
investigated in 205 neonates born before 34 weeks of pregnancy after spontaneous onset of
labour with or without PROM. This group of neonates is said to be at risk for cranial
ultrasound abnormalities such as severe intraventricular haemorrhage and cystic periventricular
leucomalacia.
Chapter 7 describes the possible influence of these perinatal events on neurodevelopmental
outcome of the group neonates described in Chapter 6. Finally a summary and a general
discussion are given in Chapter 8.
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CHAPTER 1 REVIEW
CHAPTER 1.1 TERM LAB OUR
The largest part of pregnancy is characterised by a quiescent state of the uterus. The most
important substrates responsible for uterine quiescence are progesterone and prostacyclin
(PgI2), both having an inhibitory effect on contractions 33, 34. Next to this inhibition by
progesterone and PgI2 enzymes such as prostaglandin dehydrogenase (PGDH) which is
produced by trophoblast cells, catabolise uterotonica. PGDH degrades prostaglandin E2 (PgE2)
before labour 35, 36. Perturbation of this delicate equilibrium can initiate a series of actions
resulting in labour.
Near term factors produced by the placenta, membranes and decidua and signals from the fetus
change this quiescent state and induce softening of the cervix and the occurrence of
synchronous contractions of the myometrium 33. A prerequisite for myometrial contractions is
the formation of gap-junctions and the formation of receptors for uterotonica such as
prostaglandins and oxytocin 33, 37. For softening and dilatation of the cervix degradation of the
cervical collagen is necessary 38. A number of substrates play a major role in this transition and
will be discussed shortly. For a more extensive review of the mechanisms involved in human
parturition refer to Keelan 33, Challis 35 and Mitchell 39.
Prostaglandins play a major role in the onset and continuation of parturition 39, 40. PgE2 is he
most important component and is mainly produced by the amnion. PgE2-levels rise near the
end of pregnancy 5, 40. Synthesis of PgE2 is dependent on the availability of arachidonic acid,
which is a substrate for prostaglandin synthesis. Phospholipase A2 (PlA2) is an enzyme
necessary for the release of arachidonic acid from phospholipids and PlA2 expression increases
near the end of term 37, 40. Another enzyme necessary for the synthesis of prostaglandins is
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prostaglandin H hydrogenase (PGHS) whose activity also increases near term 40, 41. The
production of PGDH, an enzyme that catabolises PgE2, d creases near term especially in the
area of the lower uterine segment 42. The cessation of PGDH production might be controlled
by the local progesteron-estrogen ratio 42. Diminished action of the inhibitory and degrading
system results in increased bioavailability of PgE2, a prostaglandin playing a major role in
parturition 33, 35, 39, 40. This increase in PgE2 levels results in gap-junction formation and
increased contractility 33.
Corticotrophin releasing hormone (CRH) is produced by the fetus and also in the placental
syncytiotrophoblast cells. CRH production increases near term. Activation of the fetal
hypothalamic-pituitary-adrenal (HPA) axis as a result of maturation of the fetal organism
induces CRH production and secretion of dehydroepiandrosterone sulphate (DHEAS) by
increased activity of the fetal adrenals 43. In p acental and decidual tissues, DHEAS is
metabolised in estrogens decreasing the progesteron-estrogen ratio 44. CRH i duces PgE2
synthesis and can augment the oxytocin-generated contraction by binding to CRH-receptors 43.
Besides PgE2, platelet activating factor (PAF) has potent contractile properties and is produced
by the fetal lungs. Synthesis increases near term concomitant with fetal lung maturation.  It
reaches the myometrium through the membranes. Prior to term PAF is inactivated by PAF-
acetylhydrolase (PAFAH) which is produced by decidual macrophages. Estrogens whose levels
rise near term decrease the production of PAFAH 45.
Oxytocin is another powerful uterotonicum. In term labour there is no increase in the levels of
oxytocin. The effects of oxytocin are realised by increased sensitivity for oxytocin of the
myometrium as a result of an increase of oxytocin receptors. Locally produced prostaglandins
and estrogens influence this receptor expression. Binding of oxytocin to its receptor stimulates
in turn prostaglandin production 45, 46.
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In the process of parturition, major changes have to occur in the cervical part of the uterus.
This rigid, collagen rich part of the uterus has to soften and dilate. Interleukin-8 (IL-8), a
cytokine, plays a pivotal role in the changes taking place in the cervix during labour 38. IL-8
production is controlled by progesterone and when levels of progesterone decrease in the
lower uterine segment near term, the production of IL-8 increases 42. IL-8 induces chemotaxis
as a result of which polymorphonuclear granulocytes (PMN) migrate into the cervix, where
collagenases and elastases are released from the PMN’s granulae resulting in the degradation
of the collagen structure in the cervix, which leads to softening 47. Pr staglandin production is
also enhanced by IL-8.
Therefore, the process of preparing the uterus for labour and birth is characterised by a
complex interplay between substrates produced by various gestational tissues. The exact
mechanism is still not fully understood.
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CHAPTER 1.2 PRETERM LABOUR
Although preterm labour and delivery may result from heterogeneous pathological conditions
roughly two major pathways may lead to preterm birth 13, 14, 15, 34:
· the fetus can initiate labour through activation of the HPA axis resulting in an increase of
CRH production
· cytokines released as a result of an inflammatory reaction either due to trauma, bleeding or
microbial infection at the chorio-decidual interface can activate PgE2 production 48
These changes must be powerful enough to overcome the inhibitory systems protecting the
myometrium from contractions and the cervix from softening.
Besides fetal stress and fetal hypoxia, maternal stress can also stimulate the fetal HPA axis and
induce secretion of CRH 43, 49, 50 leading to PgE2 production. This results in contraction of the
uterus and softening of the cervix through various mechanisms as discussed in the first part of
this chapter.
The other pathway, through which preterm labour can be initiated, is an inflammatory reaction
at the chorio-decidual interface. This inflammatory reaction of the decidua leads to a release of
cytokines, mostly interleukin-1 (IL-1) and tumor necrosis factor (TNF). Decidual macrophages
and polymorphonuclear leukocytes (PMN) can react to this inflammatory reaction and migrate
to the chorio-decidual interface. IL-1 and TNF initiate production and secretion of interleukin-
6 (IL-6), IL-8 and PgE2 from these decidual macrophages 40. IL-8 stimulates migration of
PMN 38 and these cells can release cytokines, collagenases and proteases. The latter enzymes
are capable of weakening the membranes resulting in PROM or softening of the cervix
depending on the site of reaction 18, 35, 38.
Cytokines can induce the synthesis of the enzymes PlA2 and PGHS both necessary for the
synthesis of PgE2 39, 40. Cytokines also lead to PgE2 production in the amnion. Through
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stimulation of CRH production in the placental tissue, cytokines have another impact on
increased PgE2 production. Chorion inflammation and infection can lead to necrosis of
trophoblast cells and cause the production of PGDH to drop, which facilitates the availability
of prostaglandins for the myometrium 36, 51.
The inflammatory reaction in the decidua also leads to decreased production of PAFAH
resulting in stimulation of the myometrium by PAF. This substrate stimulates the amnion to
increased PgE2 output 45. Micro-organisms found in infections of the uterine cavity excert PlA2
activity 52. Bacterial products such as lipopolysaccharide (LPS) are also capable of stimulating
the synthesis of cytokines 53, 54.
A congenital deficiency of PGDH is another possible condition leading to preterm birth. In
those cases any stimulus resulting in an increased PgE2 production will inevitably result in
parturition because of decreased catabolism of prostaglandins 35, 51.
Although the final pathway leading to parturition (i.e. PgE2 incr ase) is the same for both
preterm and term labour the triggers are different. In term labour, there is a maturation of all
gestational tissues including the fetus leading to increased PgE2 levels. In preterm birth, either
the fetus via CRH or an inflammatory reaction of the decidua leading to cytokine production
initiates the PgE2 pathway. The inflammatory reactions may occur at various sites in the uterus
or fetus. The cascade of reactions leading to labour may undergo arrest spontaneously or may
be arrested due to drugs intervening in the activated pathway. This is in contrast to term labour
where tocolysis is rarely successful 34.
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CHAPTER 1.3 THE RELA TIONSHIP BETWEEN MICRO-ORGANISMS AND
PRETERM BIRTH
Preterm birth can be caused by inflammation at the chorio-decidual interface through release of
cytokines resulting in PgE2 production and through a decrease of PgE2 inhibition. We sought
to discover whether micro-organisms were involved in this inflammatory process.
The incidence of chorioamnionitis is significantly higher in preterm birth when compared to
term delivery 16-24 where in preterm labour without PROM cultures of the amniotic fluid show
growth of micro-organisms in up to 16% 18. In those cases tocolytic therapy seldom was
successful 55. Various micro-organisms found in the vagina have been associated with
increased risk for preterm labour but no single organism could be identified as having a causal
relationship 3. Bacterial vaginosis is a condition where the normal lactobacilli-dominant vaginal
flora is replaced by anaerobe micro-organisms 23 d a relationship with premature birth has
been demonstrated in various articles 20, 21, 22, 24.
The incidence of early onset neonatal infection (sepsis or pneumonia) is increased in preterm
born infants 26, 56, 57, 58 and there is a significant relationship between a clinical and histological
chorioamnionitis and early neonatal infections 58. It is generally assumed that the majority of
early neonatal infections already start in the uterus.
Chorioamnionitis and early onset neonatal infections are associated with cerebral palsy 9, 10, 11,
59, 60, 61. The cytokines released in preterm labour are thought to play a role in the onset of
cerebral palsy 59, 60, 61. The incidence of endometritis after preterm birth is significantly higher
compared to the incidence after term delivery 17, 26.
Antibiotic treatment has shown to be partially successful in decreasing the incidence of preterm
birth. In women at high risk for preterm delivery with bacterial vaginosis antibiotic therapy
early in gestation decreased the incidence of preterm birth significantly 27, 28.
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Maternal antibiotic therapy in cases with preterm PROM between 24 and 34 weeks increased
rupture-to-delivery interval and decreased incidence of neonatal sepsis and pneumonia
significantly 29-32.
These data strongly suggests that micro-organisms are causally involved in a certain
percentage of preterm birth when preceded by contractions or rupture of the membranes 17.
21 \ 155
CHAPTER 1.4 REFERENCES
1 Villar J, Ezcurra EJ, Gurtner de la fuente V, Campodonico L. Pre-term delivery: the unmet
need. Res Clin Forums 1994; 16: 6-38.
2 Lumley J. The epidemiology of preterm birth.  Bailliere Clin Ob Gyn 1993; 7(3): 477-98.
3 Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth
and subclinical infection. Am J Obstet Gynecol 1992; 166(5): 1515-28.
4 Rutter N. The extremely preterm infant. Br J Obstet Gynaecol 1995; 102(9): 682-7.
5 Keirse MJ. New perspectives for the effective treatment of preterm labor.  Am J Obstet
Gynecol 1995; 173(2): 618-28.
6 Hack M, Fanaroff AA. Outcomes of extremely-low-birth-weight infants between 1982 and
1988.  N Engl J Med  1989; 321(24): 1642-7
7 Robertson PA, Sniderman SH, Laros RKJ, Cowan R, Heilbron D, Goldenberg RL, Iams
JD, Creasy RK. Neonatal morbidity according to gestational age and birth weight from five
tertiary care centers in the United States, 1983 through 1986.  Am J Obstet Gynecol 1992;
166: 1629-41.
8 Lefebvre F, Glorieux J, St-Laurent-Gagnon T. Neonatal survival and disability rate at age
18 months for infants born between 23 and 28 weeks of gestation.  Am J Obstet Gynecol
1996; 174(3): 833-8.
9 Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM. Case-control study of
antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies.
Lancet 1995; 346(8988): 1449-54.
10 Spinillo A, Capuzzo E, Stronati M, Ometto A, Orcesi S, Fazzi E. Effect of preterm
premature rupture of membranes on neurodevelopmental outcome: follow up at two years
of age.  Br J Obstet Gynaecol 1995; 102(11): 882-7.
11 Grether JK, Nelson KB, Emery ES, Cummins SK. Prenatal and perinatal factors and
cerebral palsy in very low birth weight infants. J Pediatr 1996; 128(3): 407-14.
12 Holzman C, Paneth N, Fisher R and the MSU Prematurity Group. Rethinking the concept
of risk factors for preterm delivery: antecedents, markers and mediators. Prenat Neonat
Med 1998; 3: 47-52.
13 Savitz DA, Blackmore CA, Thorp JM. Epidemiologic characteristics of preterm delivery:
etiologic heterogeneity.  Am J Obstet Gynecol 1991; 164(2): 467-71.
14 Arias F, Rodriquez L, Rayne SC, Kraus FT, Gibbs RS, Romero R, Hillier SL, Eschenbach
DA, Sweet RL. Maternal placental vasculopathy and infection: two distinct subgroups
among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol
1993; 168: 585-91.
15 Lettieri L, Vintzileos AM, Rodis JF, Albini SM, Salafia CM. Does "idiopathic" preterm
labor resulting in preterm birth exist?  Am J Obstet Gynecol 1993; 168(5): 1480-5.
16 Iams JD, Goldenberg RL, Meis PJ, Mercer BM et al. The length of the cervix and the risk
of spontaneous premature delivery. N Engl J Med 1996; 334: 567-72.
22 \ 155
17 Gomez R, Ghezzi F, Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-
amniotic infection. Clinical aspects and role of the cytokines in diagnosis and
pathophysiology. Clin Perinat 1995; 22(2): 281-342.
18 Romero R, Ghidini A, Mazor M, Behnke E. Microbial invasion of the amniotic cavity in
premature rupture of membranes.  Clin Obstet Gynecol 1991; 34(4): 769-78.
19 McGregor JA, French JI, Lawellin D, Todd JK, Greaves WL, Chungafung J, Morris B,
Haile A, Townsend JL, Livengood CH, et al.  Preterm birth and infection: pathogenic
possibilities. Am J Reprod Imm Microbiol 1988; 16(3): 123-32.
20 Hillier SL, Nugent RP, Eschenbach DA, Krohn MA, Gibbs RS, Martin DH, Cotch MF,
Edelman R, Pastorek JG, Rao AV. Association between bacterial vaginosis and preterm
delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group.
N Engl J Med 1995; 333(26): 1737-42.
21 Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ, Ison C, Pearson J. Abnormal
bacterial colonisation of the genital tract and subsequent preterm delivery and late
miscarriage. BMJ 1994; 308(6924): 295-8.
22 McDonald HM, O'Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ. Prenatal
microbiological risk factors associated with preterm birth.  Br J Obstet Gynaecol 1992;
99(3): 190-6.
23 Spiegel CA. Bacterial vaginosis.  Clin Microbiol Rev 1991; 4(4): 485-502.
24 McCoy MC, Katz VL, Kuller JA, Killam AP, Livengood  CH. Bacterial vaginosis in
pregnancy: an approach for the 1990s.  Obstet Gynecol Surv 1995; 50(6): 482-8.
25 Hillier SL, Martius J, Krohn M, Kiviat N, Holmes KK, Eschenbach DA. A case-control
study of chorioamnionic infection and histologic chorioamnionitis in prematurity.  N Engl J
Med 1988; 319(15): 972-8.
26 Seo K, McGregor JA, French JI. Preterm birth is associated with increased risk of maternal
and neonatal infection. Obstet Gynecol 1992; 79: 75-80.
27 Morales WJ, Schorr S, Albritton J.  Effect of metronidazole in patients with preterm birth in
preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study.  Am
J Obstet Gynecol 1994; 171: 345-347.
28 Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of
preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis.
N Engl J Med 1995; 333(26): 1732-6.
29 Ananth CV, Guise JM, Thorp JM, Jr. Utility of antibiotic therapy in preterm premature
rupture of membranes: a meta-analysis.  Obstet Gynecol Surv 1996; 51(5): 324-8.
30 Egarter C, Leitich H, Karas H, Wieser F, Husslein P, Kaider A, Schemper M. Antibiotic
treatment in preterm premature rupture of membranes and neonatal morbidity: a
metaanalysis.  Am J Obstet Gynecol 1996; 174(2): 589-97.
31 Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm
premature rupture of the membranes.  Lancet 1995; 346(8985): 1271-9.
32 Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, Rabello
YA, Meis PJ, Moawad AH, Iams JD, et al.  Antibiotic therapy for reduction of infant
morbidity after preterm premature rupture of the membranes. A randomized controlled trial.
23 \ 155
National Institute of Child Health and Human Development Maternal-Fetal Medicine Units
Network.  JAMA 1997; 278(12): 989-95.
33 Keelan JA, Coleman M, Mitchell MD. The molecular mechanisms of term and preterm
labor: recent progress and clinical implications.  Clin Obstet Gynecol 1997; 40(3): 460-78.
34 Schneider H. Pharmacological interventions in pre-term labour. Res Clin Forums 1994; 16:
59-88.
35 Challis JRG, Mitchell MD.  Basic mechanisms for pre-term labour. Res Clin Forums 1994;
16: 39-52.
36 van Meir C, Sangha RK, Walton JC, Matthews SG, Keirse MJ, Challis, JR. Immunoreactive
15-hydroxyprostaglandin dehydrogenase (PGDH) is reduced in fetal membranes from
patients at preterm delivery in the presence of infection. Placenta 1996; 17(5-6): 291-7.
37 Chow L, Lye SJ. Expression of the gap junction protein connexin-43 is increased in the
human myometrium toward term and with the onset of labor.  Am J Obstet Gynecol 1994;
170(3): 788-95.
38 Osmers RG, Blaser J, Kuhn W, Tschesche H. Interleukin-8 synthesis and the onset of labor.
Obstet Gynecol 1995; 86(2): 223-9.
39 Mitchell MD, Trautman MS, Dudley DJ. Immunoendocrinology of preterm labour and
delivery.  Bailliere Clin Ob Gyn 1993; 7(3): 553-75.
40 Mitchell MD, Romero RJ, Edwin SS, Trautman MS. Prostaglandins and parturition.
Reprod Fert Dev 1995; 7(3): 623-32.
41 Edwin S, Trautman MS, Mitchell MD. Regulation of prostaglandin H synthase-2 in chorion
and decidual cells.  Prost Leuk Ess Fatty Acids 1996; 55(4): 211-6.
42 van Meir C, Ramirez MM, Matthews SG, Calder AA, Keirse MJ, Challis, JR. Chorionic
prostaglandin catabolism is decreased in the lower uterine segment with term labour.
Placenta 1997; 18(2-3): 109-14.
43 Challis JR, Matthews SG, Van MC, Ramirez MM. Current topic: the placental
corticotrophin-releasing hormone-adrenocorticotrophin axis. Placenta 1995; 16(6): 481-
502.
44 Mazor M, Hershkovitz R, Chaim W, Levy J, Sharony Y, Leiberman JR, Glezerman M.
Human preterm birth is associated with systemic and local changes in progesterone/17 beta-
estradiol ratios.  Am J Obstet Gynecol 1994; 171(1): 231-6.
45 Toyoshima K, Narahara H, Furukawa M, Frenkel RA, Johnston JM. Platelet-activating
factor. Role in fetal lung development and relationship to normal and premature labor. Clin
Perinat 1995; 22(2): 263-80.
46 Takemura M, Kimura T, Nomura S, Makino Y, Inoue T, Kikuchi T, Kubota, Tokugawa Y,
Nobunaga T, Kamiura S. Expression and localization of human oxytocin receptor mRNA
and its protein in chorion and decidua during parturition. J Clin Inves 1994; 93(6): 2319-23.
47 Chwalisz K, Benson M, Scholz P, Daum J, Beier HM, Hegele-Hartung C. Cervical ripening
with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in
guinea-pigs.  Human Reproduction 1994; 9(11): 2173-81.
48 McGregor JA. Prevention of preterm birth: New initiatives based on microbial-host
interactions. Obstet Gynecol Surv 1988; 43: 1-13.
24 \ 155
49 Lou HC, Nordentoft M, Jensen F, Pryds O, Nim J, Hemmingsen R. Psychosocial stress and
severe prematurity. Lancet 1992; 340: 54.
50 De Mulder X, Wesel S, Dramaix M, Candeur M. A women`s attitude toward pregnancy.
Can it predispose her to preterm labour? J Reprod Med 1992; 37: 339-42.
51 van Meir C, Matthews SG, Keirse MJ, Ramirez MM, Bocking A, Challis, JR. 15-
hydroxyprostaglandin dehydrogenase: implications in preterm labor with and without
ascending infection.  J Clin Endocrinol Metab 1997; 82(3): 969-76.
52 Bejar R, Curbello V, Davis C, Gluck L. Premature labor. II. Bacterial sources of
phospholipase. Obstet Gynecol 1981; 57: 479-82.
53 Bennett PR, Rose MP, Myatt L, Elder MG. Preterm labor: Stimulation of arachidonic acid
metabolism in human amnion cells by bacterial products. Am J Obstet Gynecol 1987; 156:
649-55.
54 Lamont RF, Anthony F, Myatt L, Booth L, Furr PM, Taylor-Robinson D. Production of
prostaglandin E2 by human amnion in vitro in response to addition of media conditioned by
microorganisms associated with chorioamnionitis and preterm labor.  Am J Obstet Gynecol
1990; 162(3): 819-25.
55 Hameed C, Tejani N, Verma UL, Archbald F. Silent chorioamnionitis as a cause of preterm
labor refractory to tocolytic therapy. Obstet Gynecol 1984; 149: 726-30.
56 Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association of occult amniotic fluid
infection with gestational age and neonatal outcome among women in preterm labor.
Obstet Gynecol 1992; 79(3): 351-7.
57 Alexander JM, Gilstrap LC, Cox SM, McIntire DM, Leveno KJ. Clinical chorioamnionitis
and the prognosis for very low birth weight infants. Obstet Gynecol 1998; 91: 725-9.
58 Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis.
Obstet Gynecol 1996; 87: 188-94.
59 Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link?  Dev
Med Child Neurol 1993; 35(6): 553-8.
60 Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the
preterm newborn.  Pediatr Res 1997; 42(1): 1-8.
61 Yoon BH, Jun JK, Romero R, Park KH, Gomez R, Choi JH, Kim IO. Amniotic fluid
inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha),
neonatal brain white matter lesions, and cerebral palsy.  Am J Obstet Gynecol 1997; 177(1):
19-26.
25 \ 155
Chapter 2 Does prophylactic administration of clindamycin 2% vaginal creme
reduce the incidence of spontaneous preterm birth in women with an increased
recurrence risk? A randomised placebo-controlled double-blind study.
Gustaaf M. Vermeulen 1
Hein W. Bruinse 2
1 Department of Obstetrics and Gynaecology, Diaconessenhuis Meppel, Meppel, the
Netherlands
2 Department of Obstetrics, University Hospital Utrecht, Utrecht, the Netherlands
SUBMITTED
26 \ 155
ABSTRACT
Objective: To test the hypothesis that prophylactic administration of clindamycin 2% vaginal
creme can reduce the incidence of preterm birth in a high risk population.
Design: A multicentre, randomised, double-blind, placebo-controlled trial.
Setting: Twelve city hospitals in the Netherlands.
Participants: One hundred forty-two women with a singleton pregnancy and a history of a
spontaneous premature delivery in the preceding pregnancy.
Interventions: Clindamycin 2% vaginal creme or placebo creme daily administered for seven
days at 26 and 32 weeks of pregnancy.
Main outcome measures: Spontaneous preterm birth less than 37 weeks, admission for
threatened preterm labour and neonatal infectious morbidity.
Results: No difference was found in overall preterm birth between clindamycin and placebo
(29% versus 19% resp). In the subgroup without bacterial vaginosis more preterm birth before
34 weeks were seen in the clindamycin group (2% versus 10% resp, p<0.05). The length of
admissions for threatened preterm labour did not differ. More infectious neonatal morbidity
was seen in the clindamycin group (5/70 versus 0/72, p<0.05).
Conclusion: Clindamycin 2% vaginal creme administered prophylacticly to women with a
spontaneous preterm birth in the preceding pregnancy did not prevent preterm delivery nor
influence the number of admissions for threatened preterm labour. The increase of neonatal
infectious morbidity in the group treated with clindamycin was a major concern.
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INTRODUCTION
Premature birth before 37 completed weeks of pregnancy is a major problem in obstetrics and
neonatology. Premature birth can either be spontaneous or artificially induced as in cases of
intra uterine fetal growth retardation (IUGR); pregnancy induced hypertension (PIH) related
problems or abruptio placentae. Prevention of spontaneous premature birth is a method to
reduce the incidence of premature delivery. Educational programs, monitoring for
contractions, frequent cervical examinations and risk scoring have not shown to be effective in
reducing preterm birth 1, 2.
The cause of spontaneous premature birth is largely unknown, but accumulating evidence
suggests that inflammation and infection of the chorio-decidual interface play a role in the
onset of premature birth 3. The incidence of premature delivery increases in women with
bacterial vaginosis 4, 5, 6, where the normal lactobacilli-dominant vaginal flora is replaced by
anaerobe micro-organisms as Bacteroides species, Mobiluncus pecies, Prevotella nd
Gardnerella vaginalis 7, 8. These micro-organisms are capable of initiating the synthesis of
prostaglandins, which can lead to premature birth 3, 9.
If vaginal micro-organisms play a role in the aetiology of spontaneous premature birth, it can
be hypothesised that prophylacticly administering of antibiotics capable of restoring the normal
lactobacilli dominant vaginal flora may reduce the incidence of premature birth in a population
at high risk of premature delivery. Several studies have shown clindamycin 2% vaginal creme
to be as effective as metronidazol in the treatment of bacterial vaginosis by restoring the
lactobacilli dominant vaginal flora 10, 11, 12. At the start of this project it was the only
antimicrobial agent approved by the FDA for the treatment of bacterial vaginosis in pregnancy
and for this reason it was chosen for this study.
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To test this hypothesis clindamycin 2 % vaginal creme was given prophylacticly to women with
a spontaneous preterm birth in the preceding pregnancy at 26 and 32 weeks of pregnancy in a
randomised multicentre double-blind placebo-controlled study. This selection criterion was
chosen since preterm birth in the penultimate pregnancy remains a major risk factor 13, 14, 15.
The aim of this study was to determine whether this treatment reduces the incidence of
spontaneous preterm birth in this high-risk group.
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METHODS
Patient selection
From 1 January 1994 to 31 December 1996 pregnant women attending the antenatal clinics of
12 hospitals in the Netherlands were asked to participate in this randomised multicentre
placebo-controlled double-blind study. They fulfilled the following criteria:
· spontaneous preterm birth between 24 and 36 completed weeks of gestation in the
penultimate pregnancy with or without a preceding period of ruptured membranes;
· a viable pregnancy without major fetal congenital anomalies;
· gestational age at entry less than 26 weeks determined by menstrual history and confirmed
by ultrasound
Patients excluded from the study had previous preterm births associated with intra-uterine
growth retardation, hypertension or pre-eclampsia, placental disorders, congenital uterine
anomalies, maternal diseases or a known allergy to clindamycin. The study protocol for each
hospital was approved by its ethical committee for experiments on human beings.
Randomisation, treatment and medication
Randomisation was stratified by centre and by bacterial vaginosis since treatment for premature
labour can differ between various hospitals and bacterial vaginosis is an independent risk factor
for preterm birth 4, 5, 6. After receiving written consent a vaginal smear was taken from each
women according to the method described by Nugent et al 16. All sp cimens were analysed by
the Department of Microbiology at the University Hospital Utrecht, Utrecht, the Netherlands.
Bacterial vaginosis was considered to be present when the Nugent score was seven or more. A
research co-ordinator allocated medication or placebo using a prefixed randomisation list so
that care providers were blinded to medication and the presence of bacterial vaginosis. The
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participating women collected their medication at the pharmaceutical department of each
hospital. The medication or an identical looking placebo had to be applied for seven days
intravaginally at 26 and 32 weeks of gestation. Compliance to medication was analysed by the
evaluation of the non-collected medication at the pharmaceutical department of each hospital.
Upjohn Nederland supplied the medication and the identical looking placebo.
Outcome variables and data analysis
The main predefined outcome variable was the incidence of premature delivery. Admissions for
threatened preterm labour and neonatal infectious morbidity as defined by proven sepsis,
infectious morbidity associated with sepsis (sepsis-like disease) and pneumonia were
considered as secondary outcome variables. Apart from these variables, medication with
antibiotics other than the study medication was recorded. Women were also asked how often
sexual intercourse took place in the week preceding the scheduled visits at week 25, 31 and
35. Data were analysed using the SPSS/PC statistical software (SPSS Inc., Chicago, Illinois,
USA) and when appropriate chi-square, Wilcoxon tests and correlations were applied. A p-
value less than .05 was considered significant.
Sample size
The study aimed to achieve a sample size of 566 based on the hypothesis that treatment was
able to reduce the incidence of preterm birth from 20% to 10% with a 90% power to detect a
significance of 0.05. Several studies reported a recurrence of 20% of preterm birth in a group
of women with a spontaneous preterm birth in the preceding pregnancy 13, 14. The study was
scheduled for a three-year period and in this period the intake of eligible women was only 168.
With this number of participants the hypothesised significant reduction from 20 % to 10 % in
the incidence of preterm birth would only have had a power of 0.38. A possible cause of this
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low recruitment is that in the Netherlands the majority of women with a history of preterm
birth in the preceding pregnancy are treated in the first line of obstetrical care by independent
midwives and general practitioners and only a minority of these women is seen by
obstetricians.
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RESULTS
The studygroup consisted of 168 women with a history of preterm birth in the preceding
pregnancy and for various reasons, 26 women were excluded from analysis. This resulted in a
study group of 142 with 72 women in the placebo group and 70 in the clindamycin group.
During the study period clinicians did not find it necessary to break the blinding code for
medical reasons. Only after the last patient had delivered and the files were completed the code
was broken able (Table I).
Table I
Patients and dropouts from the study
placebo clindamycin
total number entered 85 83
withdrawal after entering 5 3
protocol violation 4 6
transfer to other hospital 3 3
birth before start of medication 1 1
suitable for analysis 72 70
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Table II shows the relevant characteristics of the two groups. No differences were found in
history of preterm births as well as the duration of the penultimate pregnancy. The number of
women with bacterial vaginosis was equally divided among the groups, as well as the number
of women who smoked.
Table II
Characteristics of women at time of randomisation
placebo(72) clindamycin(70)
age at intake in years  (sd) 30.9  (3.7) 31.4  (4.1)
history with more than one preterm birth 6 7
parity  (sd)     1.4  (0.8) 1.6 (1)
primiparae 55 45
smokers 37 44
length of penultimate gestation in days (sd) 222  (27) 223  (32)
week at intake (sd) 20.5  (3.0) 19.5  (3.8)
bacterial vaginosis at intake 8 8
(sd) = standard deviation
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The incidence of preterm delivery, the main outcome variable, did not differ between the
placebo and the clindamycin group (19% and 29% respectively) while significantly more births
occurred before 34 weeks in the clindamycin group (Table III). This difference was still present
when only those women without a bacterial vaginosis at intake were analysed. It was no longer
found in women with a bacterial vaginosis at intake. Hospital admissions for threatened
preterm labour were equal in number as well as in duration for both groups.
Table III
Outcome variables
placebo(72) clindamycin(70)
birth before 37 weeks (%) 14  (19%) 20  (29%)     ns
birth before 34 weeks(%) 1 (1.4%) 6 (9%) *
birth before 34 weeks (%) without vaginosis 1/64  (2%) 6/62 (10%) *
birth before 34 weeks (%) with vaginosis 0/8 0/8 ns
admissions for threatened preterm labour (%) 19 (26%) 20 (29%) ns
duration of admission for threatened preterm labour
in days 14.4 12.3 ns
neonatal infectious morbidity 0 5 *
ns not statistical significant
* p<0.05
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On three occasions during admission for threatened preterm labour antibiotics were given in
both groups due to lower urinary tract infection; bronchitis and fever. There was no case of
neonatal infectious morbidity in the placebo group versus five cases in the clindamycin group,
which was a significant difference of p< .05 (Table IV). One neonate in the clindamycin group
born at 32 weeks of pregnancy had a congenital pneumonia with Streptococci Pneumoniae and
the neonate died immediately after birth.
Table IV
Neonatal infectious morbidity in the clindamycin group
gestational ageclindamycin treatmenttype infection superficial prom
in weeks cultures >12 hour
26 during sepsis-like neg no
30 4 weeks after sepsis-like enterobacter no
30 2/7 4 weeks after sepsis-like e.coli no
30 6/7 4 weeks after sepsis-like group B strept yes
32 4/7 * during pneumonia strept pneumoniaeno
* died immediatly after birth
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In the five neonates with neonatal infections none of the mothers had bacterial vaginosis. The
four surviving neonates were all discharged in good condition. One fetus in the clindamycin
group died in utero. However the autopsy showed no abnormalities nor infection and the cause
of death remains unexplained.
The use of antibiotics other than the study medication did not differ in the groups (7/72 in the
placebo group versus 9/70 in the clindamycin group). Antimicrobial medication other than the
study medication was prescribed for lower urinary tract infection, bronchitis and flu like fever.
The number of incidences of sexual intercourses in the week preceding the visits at intake (0.8
in the placebo versus 0.8 in the clindamycin group), at 31 weeks (0.6 versus 0.4 resp) and at
35 weeks (0.6 versus 0.3 resp) was equal for both groups. In the `drop-out` group four
preterm births occurred in the placebo-designated group and three in the clindamycin-
designated group. The overall incidence of preterm birth in the `drop-out` group was 27%, not
different from the study group.
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DISCUSSION
It was concluded that the hypothesis that clindamycin 2% vaginal creme prophylacticly given at
26 and 32 weeks of gestation in this well randomised group of women with a history of
preterm delivery in the preceding pregnancy could reduce the incidence of preterm delivery
when compared to placebo, had to be rejected. Clindamycin 2% vaginal creme did not prevent
premature birth nor did this medication have any effect on the incidence of admissions for
preterm labour (see Table II and III). One might argue that this conclusion is invalid because
the predefined sample size was not reached. This would have been true if a difference in favour
of clindamycin had emerged; however the fact that no difference in the main outcome variable,
premature birth before 37 weeks, was found with an even significantly less favourable outcome
in the clindamycin group in preterm birth before 34 weeks, justifies this conclusion.
The incidence of spontaneous preterm birth in the study population  (19% in the placebo and
29% in the clindamycin group) indicates that the hypothesis was tested in a population with an
increased risk for premature delivery. This is in agreement with the recurrence of prematurity
using a history of premature birth in the preceding pregnancy as selection criterion 13,14,15.
Our findings are similar to the results of a study by Hauth et al 17. They tested whether
metronidazole combined with erythromycin prophylacticly given to women with an increased
risk for premature delivery (a history of preterm birth or a low prepregnancy weight (<50 kg))
could reduce the incidence of preterm birth. A group of 358 women was treated once between
22 and 24 weeks in a double-blind, placebo-controlled study. The incidence of prematurity
(22% in the medication vs. 25% in the placebo group) was not different between the groups.
In our study, clindamycin was given twice (at weeks 26 and 32) during pregnancy. We opted
for a second treatment because the therapeutic effect of antibiotics at restoring the normal
lactobacilli dominant vaginal flora varies from 75% and 90% 7, 18. Since a quarter of women
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with bacterial vaginosis is not cured after one course of treatment, a second was scheduled 6
weeks after the first treatment. Despite a second treatment, clindamycin 2% vaginal creme
showed no effect in the prevention of premature delivery. These results, together with the
study of Hauth, indicate that antibiotic prophylaxis does not prevent preterm delivery in
women with a history of premature birth in the preceding pregnancy. An alarming observation
was found in the clindamycin group where significantly more births before 34 weeks were
seen. The neonatal infectious morbidity was also significantly higher in the clindamycin group.
Two of the five neonates with infectious morbidity were born during the week that clindamycin
was administrated (26 and 32 weeks). One of them (born at 32 weeks) died of a fatal
congenital pneumonia due to Streptococci Pneumoniae infection. The others were born several
weeks after treatment.
Hillier 12 demonstrates that one week after treatment with clindamycin 2% vaginal creme the
vaginal flora was altered with a short lasting increase of Enterococci and E.coli. This was also
reported by Hill 18, who found an increase in Enterococci and aerobic Gram negative rods after
treatment with clindamycin. These findings may explain the increase in neonatal infectious
morbidity in our study.
In contrast to the inability of antibiotic prophylaxis to reduce the incidence of spontaneous
premature delivery in a group of women with a high risk of preterm birth based on the
obstetric history, Morales and Hauth found an effect of antibiotic prophylaxis in a group of
women with both an increased risk based on the obstetric history and a bacterial vaginosis 17, 19.
In the study by Morales, the incidence of preterm birth in the group treated with metronidazole
was 18% versus 39% in the placebo group. Hauth reported 31% preterm deliveries in the
group treated with metronidazole and erytromycin and 49% in the placebo group. However,
treatment with clindamycin 2% vaginal creme of women without an increased risk of preterm
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birth but with bacterial vaginosis was not successful in reducing the incidence of prematurity 20,
21.
The observed increase in birth before 34 weeks and the increase of neonatal infectious
morbidity in the clindamycin group strongly suggests that this antibiotic should not be
administered prophylacticly to women with an increased risk for spontaneous preterm delivery
with a normal vaginal flora.
At present only treatment of bacterial vaginosis in pregnant women with an increased risk of
preterm birth has resulted in a significant reduction of premature delivery. Whether treatment
of bacterial vaginosis in pregnancy without additional risk factors for prematurity is justified,
needs to be investigated.
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ABSTRACT
Objective: To analyse the alterations of vaginal flora after administering clindamycin 2%
vaginal creme or placebo during treatment for prevention of preterm delivery in a high risk
population.
Design: Observational study of a randomised multicentre double-blind placebo controlled trial.
Setting: Twelve city hospitals in the Netherlands.
Participants: Sixty-four women with a singleton pregnancy and a history of a spontaneous
premature delivery in the preceding pregnancy. A Nugent score was done at intake, at 31
weeks and at 35 weeks, and was classified into normal, intermediate and vaginosis.
Interventions: Clindamycin 2% vaginal creme or a placebo creme daily administered for seven
days at 26 and 32 weeks of pregnancy.
Main outcome variables: Changes in vaginal flora type five weeks after the first treatment and
three weeks after the second treatment.
Results: The placebo group consisted of 33 and the clindamycin group of 31 women. Vaginal
flora was similar after one and two treatment of placebo creme but altered after clindamycin
2% vaginal creme treatment from normal to intermediate and vaginosis.
Conclusion: Clindamycin 2% vaginal creme given to reduce the incidence of prematurity in
women with an increased risk for preterm birth changes the vaginal flora from the normal type
into the intermediate type and into bacterial vaginosis. This may be a result of a reduction of
the concentration in hydrogen peroxide producing lactobacilli, susceptible for clindamycin.
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INTRODUCTION
The normal type of vaginal flora of both pregnant and non-pregnant women is characterised by
high concentrations of hydrogen-peroxide producing lactobacilli 1, 2, 3, 4. In bacterial vaginosis,
the lactobacilli dominant vaginal flora is replaced by Gram negative anaerobic micro-
organisms, such as Mobiluncus and Bacteroides species, and microaerophilic organisms as
Gardnerella vaginalis 1, 4, 5. Factors responsible for the replacement of the lactobacilli
dominant vaginal flora are unknown 1, 4. Apart from the normal vaginal flora and bacterial
vaginosis an intermediate type of vaginal flora exists. In pregnancy, the normal type vaginal
flora is rather stable while alterations of the vaginal flora primarily are found in the
intermediate and vaginosis types 2, 5, 6. Bacterial vaginosis is a risk factor for preterm delivery
7,8,9,10 and the micro-organisms associated with bacterial vaginosis are capable of initiating
prostaglandin synthesis and thus initiating preterm delivery 9, 10. Prophylactic antibiotic
treatment during pregnancy, either by metronidazole orally or clindamycin 2% vaginal creme,
was not always successful in reducing the incidence of premature delivery 11,12,13,14. The ffects
of these therapies on the alteration of the vaginal flora have not yet been described.
In this study, the effects on vaginal flora were investigated in a placebo-controlled double-blind
randomised study, in which clindamycin 2% vaginal creme or a placebo creme was
administered at 26 and 32 weeks of pregnancy and was tested for its ability to reduce the
incidence of spontaneous preterm delivery. The study population consisted of a group of
pregnant women with a history of spontaneous premature delivery in the preceding pregnancy.
The aim of this part of the study was to analyse alterations of the vaginal flora after
clindamycin 2% vaginal creme or a placebo treatment. The analysis was performed by
comparing the type of vaginal flora at intake and five weeks after the first treatment and three
weeks after the second.
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METHODS
Patient selection
From 1 January 1994 until 31 December 1996 pregnant women attending the antenatal clinics
of 12 hospitals in the Netherlands were asked to participate in this randomised multicentre
placebo-controlled, double-blind study. They fulfilled the following criteria:
· spontaneous preterm birth between 24 and 36 completed weeks of gestation in the
penultimate pregnancy with or without a preceding period of ruptured membranes;
· a viable pregnancy without major fetal congenital anomalies;
· gestational age at entry less than 26 weeks determined by menstrual history and confirmed
by ultrasound.
Only those patients who fulfilled the above mentioned criteria, who had a vaginal smear taken
at entry and twice after medication and who did not use antibiotics other than the study
medication were included in this part of the study. Excluded patients were those with previous
preterm births associated with intrauterine growth retardation, hypertensive or placental
disorders, congenital uterine anomalies, maternal diseases, or a known allergy to clindamycin.
The study protocol for each hospital was approved by its ethical committee for experiments on
human beings.
Randomisation, treatment and medication
Randomisation was stratified by centre and by bacterial vaginosis. After receiving written
consent, a vaginal smear was taken from each woman according to the method as described by
Nugent et al 15. Vaginal smears were also taken at 31 weeks, five weeks after the first
treatment, and at 35 weeks, three weeks after the second treatment. All specimen were
analysed by the Department of Microbiology at the University Hospital Utrecht, Utrecht, the
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Netherlands. The vaginal flora was classified into `normal` (Nugent score 0-3), `intermediate`
(Nugent score 4-6) or `bacterial vaginosis` (Nugent score >6) 9. A medical research co-
ordinator allocated medication or placebo using a prefixed randomisation list so that care
providers were blinded to medication and the presence of bacterial vaginosis. The participating
women collected their medication at the pharmaceutical department of each hospital. The
medication or an identical looking placebo had to be applied for seven days intravaginally at 26
and 32 weeks of gestation. Compliance to medication was analysed by the evaluation of the
non-collected medication at each pharmaceutical department and the use of antibiotics other
than the study medication was carefully recorded at each visit. Upjohn Nederland supplied the
medication or an identical looking placebo.
Outcome variables and data analysis
The outcome variables were the alterations in the vaginal flora during pregnancy.
Data were entered in a SPSS system file and analysed using the SPSS/PC statistical software
(SPSS Inc., Chicago, Illinois, USA) and characteristics between groups were compared using
chi-square and Wilcoxon tests.  To analyse the changes in the vaginal flora Cohen’s kappa for
measuring similarity between two observations was calculated and a p-value < .05 was
considered significant.
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RESULTS
The study group consisted of 168 women with a history of preterm birth in the preceding
pregnancy; 26 women were excluded from analysis due to non-compliance of the study
protocol and 19 due to use of antibiotics other than the study medication. For 41 women, there
was no complete follow-up of the Nugent scores in pregnancy and 18 delivered before week
35 of pregnancy. This left 33 women in the placebo group and 31 in the clindamycin group for
final analysis (Table I).
Table I
Patients and dropouts from the study
placebo clindamycin
total number entered 85 83
withdrawal after entering 5 3
protocol violation 4 6
transfer to other hospital 3 3
birth before start of medication 1 1
antibiotic prescription 10 9
less than three Nugent scores available 23 18
birth before 35 weeks  6 12
suitable for analysis 33 31
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Characteristics of the women in these two groups showed no differences (Table II).
Table II
Characteristics of the study group
placebo n=33 clindamycin n=31
age (sd) in years 31.3  (3.7) 31.0  (4.0)
gestational age neonate (sd) in days  272 (9.8) 271 (10.3)
birth < 37 weeks 3 3
smokers 15 19
mean Nugent score at intake (sd) 2.27 (2.39) 2.32 (2.59)
`normal` score 22 21
`intermediate` score 9 6
`vaginosis` score 2 4
(sd) = standard deviation
Table III shows the alterations of the distribution of the type of vaginal flora at various
moments during pregnancy.
Table III
Distribution of type vaginal flora at intake , at 31 weeks and at 35 weeks of pregnancy
for the placebo and the clindamycin group in percentages; placebo n=33, clindamycin
n=31
type vaginal flora at intake at 31 weeks at 35 weeks
placebo   clindamycin placebo clindamycin placebo clindamycin
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normal (%) 67 68 70 45 58 42
intermediate (%) 27 19 18 35 27 32
vaginosis (%) 6 13 12 20 15 26
The change in vaginal flora between intake and week 31 and between intake and week 35 of
pregnancy is shown in Table IV with Cohen’s kappa for similarity. In the placebo group, the
types of vaginal flora at intake and after two courses of treatment showed a significant
similarity (Cohen’s kappa 0.493, p<0.001 after one course of treatment and 0.374, p=0.005
after two courses). In the clindamycin group the types of vaginal flora at intake and after one
and two courses of treatment showed no similarity (Cohen’s kappa after the first treatment
0.021 and after two treatments 0.064). The absence of similarity in the clindamycin group
results from a significant change in the normal type vaginal flora to the intermediate type and
vaginosis compared with the placebo (p<0.005, chi-square).
Table IV
Cohen`s kappa for measurement of agreement in changes in the types of vaginal flora
between intake and 31 weeks and 35 weeks for placebo and clindamycin 2% vaginal
creme  n=64
for placebo:
type vaginal flora
at intake 31 weeks 35 weeks
 normal intermediate  vaginosis normal intermediate vaginosis
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normal 22 20 1 1 16 3 3
intermediate 9 3 4 2 3 5 1
vaginosis 2 - 1 1 - 1 1
Cohen`s kappa between vaginal flora type at intake and 31 weeks 0.493, p<0.001
Cohen`s kappa between vaginal flora type at intake and 35 weeks 0.374, p=0.005
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for clindamycin:
type vaginal flora
at intake 31 weeks 35 weeks
 normal intermediate vaginosis normal intermediate vaginosis
normal 21 10 8 3 10 6 5
intermediate 6 3 1 2 2 2 2
vaginosis 4 1 2 1 1 2 1
Cohen`s kappa between vaginal flora type at intake and 31 weeks -0.021 NS
Cohen`s kappa between vaginal flora type at intake and 35 weeks 0.064, NS
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DISCUSSION
Although the patients in this study were selected by an obstetrical criterion (spontaneous
preterm birth in the preceding pregnancy), the distribution of the different types of vaginal flora
before the start of medication showed no significant differences with other pregnancy
populations (Table V) 2, 6, 16.
Table V
comparison of vaginal flora patterns
author population normal(%) intermediate(%) vaginosis(%)
Hay (6) n = 673 83.7 4.7 11.6
Hillier(9) n = 762 65.8 15.6 18.6
This study  n = 64 67 23.4 9.6
The placebo group patients applied twice a placebo that consisted of an oil and water
emulsion. Its physical and pharmacological properties are thought to be limited and considered
to be inactive to the vaginal flora. This group showed small, but not significant changes of the
vaginal flora after two courses of treatment (Table III). Cohen’s kappa demonstrated a
significant similarity between the vaginal flora at intake and after one and two courses of
treatment (Table IV). This is comparable with studies by Hillier 2 and ay 6 where the
calculated Cohen’s kappa for similarity between vaginal flora at various moments during
pregnancy varied from 0.26 and 0.46. Our results yielded similar results; so it may suggest that
the changes in vaginal flora in the placebo group do not differ from changes in vaginal flora
without application of the placebo creme.
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The clindamycin group revealed no similarity between the types of vaginal flora at intake and
the types after one and two courses of treatment; although, the initial distribution of the types
of vaginal flora did not differ from that of the placebo group (Table II and IV). This lack of
similarity after treatment reflects changes in the normal type vaginal flora. Five weeks after the
first course of treatment, a significant change from normal to intermediate and vaginosis was
detected (chi-square p<0.005, Table II and IV). Despite some temporary increases in E.coli
and other Enterobacteriaceae after clindamycin vaginal creme therapy, this persistent effect on
the vaginal flora by clindamycin has not yet been reported before 17, 18. These changes in
vaginal flora suggests that lactobacilli are susceptible to clindamycin (MIC. < 1 m/ml)17, 19. In
the normal type vaginal flora, up to 80 % of the micro-organisms are lactobacilli 1, 3, 4, 5 nd
these lactobacilli are capable of producing hydrogen-peroxide which is toxic to micro-
organisms found in bacterial vaginosis. A reduction of these hydrogen-peroxide producing
lactobacilli by clindamycin may result in an overgrowth of these catalase negative organisms.
We conclude that although clindamycin 2 % vaginal creme is a recognised therapy for bacterial
vaginosis with good cure rates in pregnant women 18, 20, 21 an opposite effect is seen when given
to women with a normal type vaginal flora. Application of clindamycin in these cases results in
the induction of an intermediate type vaginal flora or even bacterial vaginosis as demonstrated
in this study. Since bacterial vaginosis is a risk factor for preterm birth we also conclude that
obstetricians should not prescribe clindamycin 2 % vaginal creme to pregnant women with a
normal type vaginal flora.
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SUMMARY
The results of a management aimed at prolongation of pregnancy in cases of premature rupture
of membranes between 24 and 37 weeks of gestation (excluding deliveries within 24 hours)
was evaluated by comparing survival rates of the study group with national perinatal survival
data. In a group of 89 neonates there were 13 perinatal deaths, 6 in which infection played a
major role. In the group of 76 survivors, 16 neonates suffered infectious morbidity and 4 of
them showed persistent morbidity. In 62 the membranes ruptured before 34 weeks; pregnancy
was prolonged for more than 7 days in 41%. After 33 completed weeks, no prolongation of
gestation for more than one week was seen. When the membranes ruptured before week 34 of
pregnancy the management aimed at prolongation of pregnancy did improve fetal survival.
After this period survival rates did not increase by an expectant management protocol and a
10.7% infectious morbidity was observed. The fetal benefit of an expectant management after
33 completed weeks is doubtful.
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INTRODUCTION
The obstetrical management of rupture of the membranes in the preterm period is
controversial. The crucial question is whether an active management leading to delivery should
be installed out of fear for infection or whether management should be aimed at prolonging
pregnancy to obtain fetal maturation 1, 2, 3. The neonatal prognosis strongly depends on
duration of gestation, especially before 32 weeks of gestation when the premature fetus may
benefit from steroid administration 3, 4, 5.
The aim of this prospective study was to evaluate to which extend expectant management
resulted in a potentially beneficial prolongation of pregnancy of more than one week and to
evaluate whether this management improved fetal outcome. Expected survival rates at the
moment of rupture of the membranes and at moment of birth, based on national survival rates
for prematurely born neonates in the Netherlands 6, were estimated. The expected survival rate
at the moment of membrane rupture was compared with the actual survival rate to evaluate
after which period of pregnancy prolongation failed to improve fetal outcome.
Expected survival rate at birth was also compared with the actual survival rate to investigate
the possible negative effects of our management protocol on survival rates.
62 \ 155
PATIENTS AND METHODS
During the study period, women with either singleton or twin pregnancies with preterm
prolonged rupture of the membranes for more than 24 hours and who delivered between 24-37
weeks were entered in the study. Rupture of the membranes was confirmed by a positive fern
test and no vaginal or rectal examination was performed. Cultures from the distal part of the
vagina were taken for aerobic and anaerobic micro-organisms. No antibiotics were
administered except for 8 cases with proven haemolytic streptococcus group B (GBS)
colonisation of the vagina.
The management consisted of; bed rest with close monitoring for signs of intra-amniotic
infection (chorioamnionitis) by measuring rectal temperature four times a day; changes in daily
White Blood Cell Count (WBC); differences in fetal basal heart rate over 30 minutes and
changes in vaginal discharge. Tocolysis with ritodrine was administered intravenously if
contractions occurred in absence of signs of chorioamnionitis or fetal distress before 33
completed weeks and discontinued at 34 weeks.
Two doses of 8 mg of betamethasone were intramuscularly administered 24 hours apart when
gestational age on admission ranged from 26 and 34 weeks and was repeated on two-week
intervals.
When the clinical diagnosis of intra-amniotic infection was made, labour was either accepted,
induced or a Caesarean Section was performed. This diagnosis was based on body
temperatures of 37.5 °C or more, or a rise of more than 0.5 °C. One of the following signs also
had to be present; a rise in WBC of 50% or above 15 x 10*9/l; uterine tenderness; contractions
despite initially successful tocolysis; foul smelling discharge or persistent fetal tachycardia 2.
Every birth was attended by a neonatologist with swabcultures taken from the neonate's
orifices. Neonatal infections were classified as either clinical infection or sepsis. Clinical
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infection was diagnosed using signs of persistent leucocytosis, pneumonia or circulatory
problems related to suspected septicaemia. For the diagnosis sepsis a positive bloodculture was
required.
Fetal outcome parameters were either fetal demise or fetal condition at discharge from the
hospital in relation to infectious complications in the neonatal period. The actual survival rate
was compared with the expect d survival rate at birth according to the Dutch survival tables
which are based on 1338 premature live-born nfants in the Netherlands in 1983, taking both
birth weight and gestational age into account (POPS tables) 6. The actual survival rate was also
compared with the expected survival rate at the moment of membrane rupture. Fetal weight at
the moment of membrane rupture was estimated by extrapolation of the actual birth weight
percentile to gestational age at the time of membrane rupture.
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RESULTS
During the study period 136 women with membranes ruptured for more than 24 hours
delivered between 24-37 weeks. Due to incomplete data 50 women were excluded from the
analysis. The 86 patients (42 multiparae and 44 nulliparae) delivered 90 infants (4 sets of
twins) and one anencephalus was excluded from further evaluation. Three fetus died in utero,
ten in the neonatal period with the overall mortality rate at 14.6% (13/89). Intra-amniotic
infections were the main cause of death in one of the stillborn infants and in 5 of the neonatal
deaths. One stillborn infant died of early growth retardation and one of immaturity without any
sign of infection. In all perinatal deaths, membranes ruptured before 28 weeks of gestation and
the neonates were born before 29 completed weeks. Of the 76 infants who survived, 16
suffered an infection (21%) immediately after birth (5 cases with sepsis and 11 with a clinical
infection). Four of these 16 showed persistent morbidity; broncho-pulmonary dysplasia (2)
resulting from prolonged artificial ventilation for reasons of pneumonia; hydrocephaly (1); and
a facialis parese (1). Three other cases of persistent morbidity occurred but these were only
related to prematurity.
Mean birth weight was significantly lower and the mean gestational age at birth was
significantly shorter when comparing the perinatal deaths group with the group of healthy
survivors (p<.001) and comparing the group of infants with infectious morbidity (p=.002). No
differences were found in the obstetrical parameters between the perinatal deaths group with or
without infection (Table I). The duration of rupture of the membranes did not differ in
comparison to the perinatal deaths group, the infectious morbidity group and the healthy
survivors group (Table I).
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Table I
Obstetrical parameters
mean gestational agem an birth weight mean length of 
(range) in weeks (range) in grams rupture (range) in
hours
studygroup 32 1843 179
n=89 (24-37) (350-3800) (27-999)
perinatal death 26 5/7 *,** 915 *,** 265
n=13 (24-28 5/7) (350-1400) (35-788)
infectious morbidity 31 1/7 * 1861 * 155
n=16 (26 6/7-37) (800-3120) (25-826)
healthy survivors 33 1/7 ** 2038 ** 154
n=60 (28 4/7-37) (830-3800) (27-999)
 *   p=.002    Mann-Wittney-U-test
**  p<.001    idem
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The duration of membrane rupture lasting more than seven days dropped from 61 %, when
membranes ruptured before the 28th week and to 0% when membranes ruptured after 34
weeks (Table II). Perinatal mortality was only found in the group with ruptured membranes
before week 28. The correlation between the moment of rupture of membranes and duration of
rupture was significant (p=.001, coeff=-.5). No correlation between moment of birth and
duration of rupture was found.
Table II
Moment of rupture of the membranes and fetal outcome.
Moment of rupture of membranes
before 28 weeks after 27 and before after 33 weeks
34 weeks
perinatal death 13 - -
n=13
infectious morbidity 3 10 3
n=16
healthy survivors 12 23 25
n=60
cases with rupture of 17 8 -
membranes more than
seven days
n=25
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Those pregnancies where membranes were ruptured for more than seven days showed a better
actual survival rate as compared to the expected survival rate at the moment of membrane
rupture (68% versus 46%). This also holds true for those cases where membranes ruptured
before week 28 (actual survival rate 55% versus expected survival rate 35%). When the actual
survival was compared to the expected survival rate at birth no differences were found (Table
III).
Table III
Comparison of expected survival rate at ROM and at birth with actual survival rate.
expected survival rate expected survival ratectual survival rate
at moment of ROM at birth
hours of ROM
³ 24 < 48 n=28 87% 87% 96%
³ 48 < 168n=36 85% 85% 87%
³ 165 n=25 46%* 70%* 68%*
weeks of gestation at ROM
< 28 n=28 35%** 55%** 55%**
³ 28 < 34 n=34 90% 91% 100%
³ 34 n=27 95% 95% 100%
ROM : rupture of membranes
*   p< .0001 (Wilcoxon`test for matched pair samples)
**  p< .0005
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DISCUSSION
In this study, the overall mortality rate was 14.5% (13/89) and mortality was restricted to the
very premature period. When born before 28 weeks, 10 out of 17 neonates died and after 29
completed weeks no perinatal death occurred (Table I). According to the literature mortality
rate ranges from 3% and 15% and this mainly depends on the number of neonates born before
28 weeks (Table IV) 7-12. To compare the results shown in Table IV is not recommended
because the use of steroids and tocolytic drugs vary in each study.
Table IV
Review of articles on expectant management of prolonged rupture of the membranes in
the preterm period, including present study.
author            gestationalmethod: expectant n mortality rate
total under 29 weeks
Andreyko 25-36  before 33 weeks 92 3.2% 19% (3/16)
et al. 1984   steroids
(7)  tocolysis
 antibiotics
Wilson 25-36  - 143 15% 44% (12/27)
et al. 1982
(8)
Kappy 24-37  before 34 weeks 110 11% -
et al. 1979 (9)   steroids
Johnson 25-37  - 447 - 47% (14/30)
et al. 1981
(10)
Varnar 28-36  - 127 3% -
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et al. 1981
(11)
Van Dorsten 26-36  steroid when 97 3% 30% (3/10)
et al. 1985   lungprofile immature
(12)
this study 24-37  before 34 weeks 89 15% 59% (10/17)
  tocolysis, steroids
  between 26 and 34 weeks
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In this study, a continuation of pregnancy for more than seven days was achieved in 20 % of
the patients. Taking into account only those cases in which membranes ruptured before week
34 a prolongation for more than one week was observed in 41%. A prolongation of more than
a week is found in 19-41% of the cases in a study by Gibbs 2. However no studies
differentiated between gestational age at the moment of membrane rupture. In our patients, we
recognised an inverse relation between the moment and duration of membrane rupture as
mentioned earlier 13.
As shown in Table IV, others tried to evaluate the usefulness of their management protocols by
reporting the incidence of infections, mortality and morbidity 14, 15. F om a methodological
point of view, the question of whether the fetus with ruptured membranes benefits from
prolongation of pregnancy -despite the constant risk of infection- is best answered by a
prospective randomised trial, comparing an expectant management with active termination of
pregnancy. One such a trial has been performed where lung maturity was obligatory for
induction 16. Although no difference in perinatal mortality was found between the active and
expectant managed group, more fetal morbidity was encountered in the active group.
A matched case-controlled study on perinatal survival comparing those infants born within a
few days after membrane rupture with those having sustained pregnancy would be difficult to
interpret, since the influence of microbial-host interaction on the initiation of birth does play a
role but to an unknown extend 17.
As second best approach we introduced an alternative control group by comparing the actual
survival rate with the expected survival rate at the moment of membrane rupture. This
reference survival rate - the POPS-Tables 6 - is based on an investigation on perinatal mortality
in 1338 prematurely born infants in the Netherlands in 1983. This extensive Dutch
epidemiological study provides survival rates in Holland in relation to birth weight and
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gestational age at birth. Our actual survival rate exceeds the expected survival rate at the
moment of membrane rupture (Table III) in particular when membranes ruptured before 28
weeks of pregnancy. Our management protocol, including the use of tocolytic drugs and
corticosteroids, bears the theoretical risk of concealing an intra-amniotic infection and reducing
immunologic response. This could decrease actual survival compared with the expected
survival rate at birth, although others found a distinct beneficial effect of steroids in cases of
prolonged premature rupture of the membranes 3,5. We found no negative influence due to
infectious problems as far as survival was concerned.
In conclusion: the aim of our management to prolong pregnancy to increase fetal maturity,
succeeded in a potentially beneficial prolongation of more than one week in 21% of the cases.
Taking into account cases where membranes ruptured before 34 weeks the percentage rises to
41. Before 34 weeks a prolongation of pregnancy resulted in a higher survival rate when
compared to a control group. A possible negative effect, due to chorioamnionitis and its
sequelae was not found.
When membranes ruptured after 33 completed weeks of gestation the effects of an expectant
management can be doubtful. A prolongation for more than a week was not observed in any
patient. The fetal prognosis is excellent by that time and expectant management only risks the
chance of infection; 10.7% (3/28) in this study (Table II). Further investigation should
determine whether a policy of inducing labour in cases of ruptured membranes after 33
completed weeks would reduce this perinatal infection risk.
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SUMMARY
For 87 singleton pregnancies, with prolonged rupture of the membranes in the preterm period,
management was aimed at a prolongation of pregnancy. Monitoring for an intra-amniotic
infection was done according to generally excepted criteria. An intra-amniotic infection was
diagnosed in 43 patients. We tried to find postpartum conformation for such an intra-amniotic
infection by investigating the incidences of various infectious outcome parameters: placental
histology, neonatal infectious morbidity and microbiology. The sensitivity and specificity of the
‘clinical’ diagnosis intra-amniotic infection varied between 56% and 78% using the above
mentioned infection outcome parameters alone or combined. We conclude that although the
generally used monitoring system detects an intra-amniotic infection effectively, it does not
eliminate the possible presence of such an intra-amniotic infection.
76 \ 155
INTRODUCTION
The treatment of patients with prolonged rupture of the membranes in the preterm period is
generally aimed at a prolongation of pregnancy to allow fetal maturation 1-4. However,
infection remains a constant threat to both mother and child.
Chorioamnionitis and intra-amniotic infection are not uniformly defined, though often used
interchangeably. Clinical intra-amniotic infection is generally diagnosed when fever,
leucocytosis or fetal tachycardia are present 5, 6, 7. Chorioamnionitis is diagnosed when during
histopathological examination inflammatory cells are found in the amnion, the chorion or the
umbilical cord 8, 9. During an expectant management patients are monitored daily in order to
detect infection in an early stage. Such a management presupposes accurate means to detect
intra-amniotic infection antenatally.
The aim of this study was to investigate whether the generally accepted signs 6 enable us to
diagnose an intra-amniotic infection correctly, as confirmed or rejected postpartum by
histopathological and/or microbiological evidence of infection and/or neonatal infectious
morbidity. For the study group consisting of 87 women with prolonged rupture of membranes
between 24 and 37 weeks of gestation; sensitivity; specificity; positive and negative predictive
value of the ‘clinical’ diagnosis of intra-amniotic infections were assessed versus postpartum
indicators for infection.
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PATIENTS AND METHODS
During the study period, women with singleton pregnancies with preterm prolonged rupture of
the membranes for more than 24 hours delivered between week 24-37 were ntered in the
study.
Amniotic fluid leakage was confirmed by a fern test and no vaginal or rectal examination was
performed. Cultures from the distal part of the vagina were taken. Only in 14 cases with
haemolytic streptococcus group B colonisation of the vagina penicillin-V was given.
When rupture of the membranes was diagnosed, patients were admitted and hospitalised with
bedrest. They were closely monitored for signs of infection; by measuring rectal temperature
four times a day; doing daily White Blood Cell Count (WBC); monitoring fetal heart rate and
inspecting vaginal discharge.  Tocolysis with ritodrine was administered intravenously if painful
contractions occurred every ten minutes in absence of clinical signs of intra-amniotic infection
or fetal distress. The dose was increased until contractions ceased to occur and decreased as
soon as the situation stabilised.
Pulmonary maturity was not assessed and all patients with a gestational age on admission
between 26 and 34 weeks received steroids. Two doses of 8 mg betamethasone were
intramuscularly administered 24 hours apart and this was repeated at two-week intervals. After
34 weeks no tocolytic agents or steroids were given.
When clinically an intra-amniotic infection was diagnosed, labour was either accepted,
accelerated or induced, or a Caesarean Section was performed. This diagnosis was made by the
physician in charge based on a combination of body temperature exceeding 37.5oC or more or
a rise of more than 0.5oC.  One of the following signs also had to be present; a rise in WBC of
50% or above 15 x 10*9/l; uterine tenderness; secondary contractions despite initially
successful tocolysis; foul smelling discharge or persistent fetal tachycardia 6. As soon as n
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infection was diagnosed, antibiotics were given (1000 mg amoxycilline, every 6 hours and 500
mg metronidazole, every 8 hours) for at least 24 hours. Every birth was attended by a
neonatologist with swabcultures taken from the neonate's orifices. All neonates were given
aminoglycosides and penicillin and neonatal infections were classified as either sepsis or clinical
infection. A positive bloodculture determined the presence of sepsis. Clinical infection was
diagnosed by the neonatologist based on persistent leucocytosis, signs of pneumonia or
circulatory problems related to suspected, but unconfirmed septicaemia. The infection rate was
assessed for all live-borns and the infants condition was re-evaluated on discharge from the
hospital.
In all cases of neonatal death or stillborn an autopsy was performed. When an intra-amniotic
infection was likely to be the major contributory factor, mortality was labelled infectious. The
placentae were examined by a pathologist for signs of chorioamnionitis being a
polymorphonuclear cellular infiltrate in the placenta, the membranes or the umbilical cord.
Aerobic and anaerobic cultures were taken from the amniotic surface for bacterial growth.
The validity (sensitivity and specificity) of the clinical diagnosis intra-amniotic infection was
assessed using several outcome parameters, single as well as combined: histopathology of the
placenta, microbiology of the amnion and the presence of a neonatal infectious disease.
Statistics used were the Mann-Whitney-U test and the Chi-square test with significance
occurring at p<.05.
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RESULTS
During the study period 136 women with singleton pregnancies with membranes ruptured for
more than 24 hours delivered between week 24-37. Due to incomplete data, 49 patients were
excluded from the study. In half of them, the diagnosis intra-amniotic infection was made. In
the end 87 completely documented pregnancies were available for final evaluation. In 43 cases
the ‘clinical’ diagnosis of intra-amniotic infection was made (Group A) and in 44 pregnancies
this diagnosis had not been made (Group B).
Histopathological inflammation of the placenta occurred more frequently in Group A
compared to Group B (86% versus 52%, p<.001) with no differences between the groups
found regarding positive cultures of the amniotic surface or infectious morbidity of the
neonate. The gestational age at birth and length of rupture of the membranes also did not differ
(Table I).
Table I
Infectious outcome parameters in the study group (87 pregnancies)
Clinical diagnosis intra-amniotic infectionPresent(n=43)  Absent(n=44)
Group A Group B
mean gestational age in days 212 220
mean length of PROM in hours 170 274
histopathological inflammation placenta37 (86%)* 23 (52%)*
positive cultures amniotic surface 25 (58%) 17 (39%)
infectious morbidity neonate 17 (40%) 13 (30%)
any sign of infection 39 (91%) 31 (71%)
80 \ 155
significance (X2-test with Yates correction)
* p < 0,05
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The sensitivity, specificity, positive and negative predictive value of the ‘clinical’ diagnosis of
intra-amniotic infection versus different outcome parameters is shown in Table II. No clear
correlation occurred with any of the outcome variables used to validate the clinical diagnosis of
intra-amniotic infection.
Table II
Validity of clinical diagnosis intra-amniotic infection versus different "infectious"
outcome standard
outcome variable sensitivity specificity valuepos. pred. valueneg. pred. value
histological 62% 78% 86% 41%
inflammation
placenta
cultures amniotic 60% 60% 58% 62%
surface
neonatal infectious 57% 54% 57% 70%
morbidity
any sign infection 56% 76% 95% 30%
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DISCUSSION
In the preterm period, gestational age is still the predominant factor in determining neonatal
survival. Therefore, management of premature rupture of the membranes in the preterm period
is generally aimed at prolongation of pregnancy beyond 34 weeks 1, 4, 5. Ho ver, intra-
amniotic infections can increase neonatal mortality and morbidity and increase mother’s risk of
developing endometritis 7, 10, 11. The onset of infection is not related to duration of rupture of
the membranes 5. This threat of intra-amniotic infection necessitates an adequate monitoring
procedure. Commonly, this is done by using the criteria for diagnosing an intra-amniotic
infection as originally described by Gibbs 6. Using these criteria, the investigated population
was divided into two groups; one with and one without the clinical diagnosis of intra-amniotic
infection. Since no specific marker for an intra-amniotic infection has yet been found, we
compared the incidence of various infectious parameters as used by others 7, 9, 12 to evaluate the
presence of an intra-amniotic infection. The only significant difference between the groups was
found when histopathological inflammation of the placenta was compared (Table I).
Some investigators have also found a higher incidence of histopathological inflammation in
cases of a clinical intra-amniotic infection 7, 13, 14. I other studies only a relationship between
histopathological placental inflammation and prematurity was observed 13, 14.
No difference in yield of micro-organisms was found in our study concerning groups with or
without the clinical diagnosis intra-amniotic infection, which is contrast to findings of Pankuch
and Quinn 9, 12. Our systematic use of antibiotics in cases of intra-amniotic infection and
different culture techniques might explain this difference.
The incidence of neonatal infectious morbidity was not different between the groups. This
accords with Fergusons findings 15, but Garite found a small but significant difference in
frequency of infectious morbidity in cases of a clinical intra-amniotic infection 7.
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Sensitivity and specificity of the ‘clinical’ diagnosis of intra-amniotic infection varied between
50% and 80% regardless of the outcome parameters used (placental inflammation,
microbiology or infectious morbidity in the neonate), as shown is in Table II. Widening the
margins to ascertain an infection and using any sign of infection as outcome parameters did not
increase the sensitivity and specificity of the ‘clinical’ diagnosis of intra-amniotic infection. This
is reflected in the positive and negative predictive value of the ‘clinical’ diagnosis intra-
amniotic infection; an acceptable clinical positive predictive value (95%) when any sign of
infection was used as outcome parameter but an unacceptable clinical low negative predictive
value (30%) regarding infectious outcome variables.
Efforts have been made to exclude the presence of an intra-amniotic infection when women go
into labour after prolonged premature rupture of the membranes. Romero 16 us d
amniocentesis in the management of prolonged premature rupture of the membranes. Using
positive amniotic fluid cultures as marker for an intra-amniotic infection it was demonstrated
that despite the absence of clinical signs an intra-amniotic infection was often seen in patients
going into labour after prolonged premature rupture of the membranes. However, Gonik 18
demonstrated that amniocentisis was only successful in 56% (400 cases) in obtaining amniotic
fluid. Furthermore the clinical value of amniocentesis has not yet been established.
To refine the antepartum diagnosis of intra-amniotic infection besides amniocentesis for direct
Gram stains and bacterial cultures, C-reactive protein measurements have been added in
managing patients with prolonged rupture of membranes. The validity of C-reactive protein
measurements is controversial with a specificity and sensitivity ranging between 55-100% and
56-88% respectively 19.
To date, we are still unable to diagnose clinically an intra-amniotic infection. Since it has been
demonstrated that intra-partum administration of antibiotics in cases of suspected intra-
amniotic infection significantly reduced neonatal infectious morbidity 20, 21 and that an intra-
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uterine infection cannot be ruled out before birth, it may be justified to administer antibiotics to
all women in labour with a history of prolonged rupture of the membranes in the preterm
period.
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ABSTRACT
Objective: The aim of this study was to identify risk factors for ultrasound abnormalities in
neonates born after spontaneous preterm labour with or without premature rupture of the
membranes (PROM).
Methods: Retrospectively, a group of neonates born between 24 and 34 weeks in a tertiary
referral hospital after spontaneous onset of labour with or without prolonged rupture of the
membranes was studied. Medical records of mother and child were analysed for antenatal and
postnatal variables and cranial ultrasound was performed in the neonatal period. Abnormal
results were classified as severe intraventricular haemorrhage and cystic periventricular
leucomalacia. A stepwise forward logistic regression was performed to analyse the influence of
antenatal and postnatal variables.
Results: During the study period, there were 8958 deliveries and 229 of these fulfilled the entry
criteria including 43 twin gestations. After a review of the cases 205 neonates were suitable for
analysis and ultrasound abnormalities were identified in 27 infants. Gestational age at birth
(Odds ratio for increase per day 0.96, 95% confidence interval 0.93-0.99, p=0.03) and a full
course of antenatal steroids (OR 0.33, 95% CI 0.13-0.85, p=0.02) reduced the risk for cranial
ultrasound abnormalities. An early onset infection (OR 3.09, 95% CI 1.24-7.70, p=0.01)
increased the risk for cranial ultrasound abnormalities.
Conclusion: Gestational age at birth, an absence of a full course of antenatal steroid
administration and an early onset infection are independent variables significantly associated
with cranial ultrasound abnormalities in the very preterm neonate born after spontaneous
labour with or without PROM.
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INTRODUCTION
Recent studies have shown that neonates born after spontaneous preterm labour or prolonged
rupture of the membranes in the preterm period (PROM) are at increased risk for
intraventricular haemorrhage and cystic periventricular leucomalacia when compared to
premature neonates born after an elective delivery due to fetal growth restriction (FGR) or
maternal complications 1-9. Large intraventricular haemorrhages with or without parenchymal
involvement and cystic periventricular leucomalacia can be detected using cranial ultrasound
examination in the early neonatal period 3, 4, 10, 11. Preterm birth after spontaneous onset of
labour with or without PROM is often associated with inflammation and infection of the
uterus, membranes or placenta by bacterial vaginosis related micro-organisms 12. Leucotri s,
cytokines and prostaglandins play an important role in the onset of preterm birth. Some of
these substances are believed to be responsible for the increased vulnerability of the neonatal
brain after spontaneous preterm delivery 13-17.
The aim of this study was to investigate the relationship of antenatal and postnatal variables
with the development of large intraventricular haemorrhage and cystic periventricular
leucomalacia in a group of neonates born after spontaneous onset of labour with or without
PROM between 24 and 34 weeks of gestation.
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MATERIALS AND METHODS
All medical records of women who delivered in the period from 1 January 1990 to 31
December 1995 at the University Hospital Utrecht, a tertiary obstetrical referral hospital in the
centre of the Netherlands, were reviewed for preterm birth after spontaneous onset of labour
with or without PROM between 24 and 34 weeks of gestation. Gestational age was calculated
from the first day of the last menstrual cycle and if necessary, adjusted by early ultrasound
estimates of gestational age. Only neonates from either singleton or twin pregnancies who
were born in the University Hospital Utrecht and were admitted to the neonatal intensive care
unit (NICU) of the associated Wilhelmina’s Children’s Hospital, were included in the analysis.
Those excluded from the study were: neonates who died during delivery or before admission to
the NICU; neonates from higher order gestation; neonates electively delivered because of fetal
growth restriction (FGR), maternal pregnancy induced hypertension or preeclampsia, abruptio
placentae or placenta previa; or neonates with severe congenital anomalies.
From those who were selected for the study the following variables were recorded from
maternal and neonatal medical records:
· twin pregnancy
· use of tocolytics (intravenously administered ritrodine)
· use of antenatal corticosteroids (betamethasone) in either an incomplete or a full course of
antenatal corticosteroids (two doses given with an interval of 24 hours at least 48 hours
before birth)
· use of antibiotics (amoxicilline with or without clavulanic acid) before and during delivery
· duration of rupture of membranes
· presence of an intra-amniotic infection as defined by intrapartum fever (> 37.8° C) in
combination with either fetal tachycardia, foul smelling discharge, uterine tenderness or
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maternal leucocytosis (> 15,000 leucocytes / ml) 18
· mode of delivery (vaginal or caesarean section)
· gestational age at birth and birth weight
· five minute Apgar score of less than 7
· use of antibiotics immediately after birth
· early onset infection defined by sepsis (positive blood culture in an infected infant), clinical
sepsis (clinical suspicion of infection in a symptomatic infant) and congenital pneumonia
(characteristic infiltrates noted on a chest x-ray) all diagnosed  during the first 48 hours of
life  18
· assisted ventilation and duration of ventilation
· results of cranial ultrasonography (normal or abnormal).
Cranial ultrasound using a UM-4 mechanical sector scanner with a rotating scan head (5-7.5-
10 MHz transducer) was performed daily on all neonates during the first week of life and twice
a week until discharge from the NICU. Ultrasound findings were considered abnormal when a
large intraventricular haemorrhage with or without unilateral parenchymal involvement (grade
III or IV according to Papile 11) or cystic periventricular leucomalacia (grade II or III
according to de Vries 10) was diagnosed upon admission to the NICU.
Data were analysed using the SPSS statistical software (SPSS Inc., Chicago, Illinois, USA)
and differences between categories were tested for significance using the Chi-square test and if
applicable Wilcoxon’s test. The influence of the perinatal variables on the development of
abnormal ultrasound findings was analysed by a stepwise forward logistic regression to
investigate the interaction between these variables. Significance and odds ratio (OR) with 95%
confidence interval (CI) were calculated. This logistic regression was performed for the total
group as well as for the group of neonates that survived and a p-value <0.05 was considered
significant.
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RESULTS
There were 8958 deliveries in the University Hospital Utrecht from 1 January 1990 until 31
December 1995. Of these women 229 fulfilled the entry criteria (2.5%) including 43 twin
pregnancies. In total 272 neonates were born between 24 and 34 weeks after spontaneous
onset of labour with or without PROM . For various reasons 67 neonates were excluded; 60
admitted to another NICU than the Wilhelmina’s Children Hospital; 5 stillbirths and 2
congenital anomalies (Table I).
Table I
Study population
total number of deliveries 8958
mothers with preterm birth between 24 and 34 weeks
after spontaneous labour or prelabour rupture of membranes 229
twin pregnancies 43
total number neonates 272
excluded because of :
· stillbirth    5
· severe congenital anomaly 2
· not admitted to Wilhelmina’s Children Hospital’s NICU     60
neonates suitable for analysis  205
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neonates not surviving the neonatal period    16
Of 205 neonates including the non-survivors born between 24 and 34 weeks after spontaneous
onset of labour with or without PROM, all perinatal variables were available for analysis. In
Table II some maternal and neonatal characteristics are shown. Nulliparae were significantly
younger than multiparae. Sixteen neonates in all died during the neonatal period, fourteen due
to untreatable respiratory problems, one due to a sepsis and one due to severe cerebral
damage. Neonates who died had a significantly lower gestational age and birth weight.
Table II
Maternal and neonatal characteristics
mothers: n=164
age mean in years (sd) 29 (5)
age nulliparae in years (sd) 28 (5)*
age multiparae in years (sd)30 (5)*
twin pregnancies 43
neonates: n=205
number gestational age in days (sd)birth weight in grams (sd)
all neonates 205 202 (12) 1297 (318)
survivors 189 202 (12)** 1291 (318)*
non survivors 16 191 (10)** 1073 (249)*
* p < 0.01 ** p < 0.005
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The severe cranial ultrasound abnormalities consisted of intraventricular haemorrhage with
venous infarction found in 13 neonates (in non-survivors 4), intraventricular haemorrhage with
ventricle dilatation in 4 neonates and cystic periventricular leucomalacia in 10 neonates (in
non-survivors 2).
In an univariate analysis the influence of all perinatal variables on cranial ultrasound
abnormalities was investigated (Table III). In neonates with an abnormal ultrasound, the
following significant differences were seen when compared to those without cranial ultrasound
abnormalities:
· duration of tocolysis was shorter (p<0.01)
· any form of steroids was less frequently given (p<0.01)
· a full course of antenatal steroids was less frequently given (p< 0.005)
· antibiotics during labour were less frequently administered (p<0.05)
· the incidence of caesarean sections was lower (p<0.05)
· gestational age at birth was lower (p<0.05)
· more early onset infections were seen (p<0.005)
· assisted ventilation was longer (p<0.05).
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Table III
Perinatal variables and the results of ultrasound
normal ultrasound abnormal ultrasound
all survivors all survivors
Number 178 168 27 21
Variable
tocolysis (%) 87.6 87.4 74.1 76.2
length of tocolysis (sd) 3.7 (4.5)** 3.9 (4.1)** 1.7 (1.6)** 1.5
(1.6)**
antibiotics before birth (%) 21.3 22.2 7.4 9.5
any form of steroids (%) 87.1** 87.5** 66.6** 66.6**
full course of antenatal steroids (%)57.9*** 60.1*** 25.9*** 19***
antibiotics during labour (%) 48.3 48.5* 29.6 23.8*
intra-amniotic infection (%) 39.3 39.3 37 33.3
length of ruptured
membranes in hours (sd) 127 (243) 120 (230) 56 (192) 22 (38)
caesarean section (%) 32.6* 33.9* 14.8* 9.5*
gestational age in days (sd) 203 (12)* 203 (12)* 196 (10)* 198 (10)*
birth weight in grams (sd) 1294 (320) 1304 (315) 1191 (302) 1223 (329)
girls (%) 40.4 41.0 37.0 38.1
boys (%) 59.6 59.0 63 61.9
low five minute apgar score (%)12.9 11.9 14.8 14.3
early onset infectious disease (%)42.1*** 39.2*** 70.4*** 71.4***
antibiotics postnatally (%) 94.4 94.0 96.3 95.2
assisted ventilation (%) 78.3* 77.4* 96.3* 95.2*
length of assisted
ventilation in days (sd) 10.4 (13.6)*10.6 (13.9)*16.7 (18.3)*17.9 (18.8)*
twin pregnancies 40.4 40.7 37.0 33.3
significance of those with normal ultrasound compared to those with abnormal ultrasound
* p < 0.05
** p < 0.01
*** p < 0.005
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A stepwise forward logistic regression analysis was performed to assess the independent
influence of the perinatal variables on the development of cranial ultrasound abnormalities for
the total group of neonates as well as for the survivors (Table IV). The risk for developing
abnormal cranial ultrasound appeared to be reduced in neonates with increasing gestational age
at birth (OR for increase per day 0.96, 95% CI 0.92-0.99, p=0.03) and after a full course of
antenatal steroid administration (OR 0.33, 95% CI 0.13-0.85, p=0.02). An early onset
infection increased the risk (OR 3.09, 95% CI 1.24-7.70, p=0.01). All other variables did not
contribute significantly to the model and showed a p>0.1.
In the group that survived, the risk for abnormal cranial ultrasound decreased after a full
course of antenatal steroids (OR 0.16, 95% CI 0.05-0.51, p=0.005) and increased in neonates
that developed an early onset infection (OR 3.51, 95% CI 1.26-9.76, p=0.01). All other
variables did not contribute significantly to the model; although, some variables (antibiotics
during labour, gestational age, caesarean section, and the duration of ventilation) almost
reached significance.
Table IV
Logistic regression with ultrasound as dependent variable in the total group and the
survivors
total group n = 205 significanceodds ratio (95% CI)
gestational age at birth p=.0272 0.96 (0.92-0.99)
full course of antenatal steroidsp=.0162 0.33 (0.13-0.85)
early onset infection p=.0115 3.09 (1.24-7.70)
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survivors n = 189 significanceodds ratio (95% CI)
full course of antenatal steroidsp=.005 0.16 (0.05-0.51)
early onset infection p=.01 3.51 (1.26-9.76)
antibiotics during labour p=.053 0.34 (0.09-1.25)
caesarean section p=.057 0.53 (0.24-1.17)
gestational age at birth p=.052 0.97 (0.91-1.02)
length of assisted ventilation p=.056 1.01 (0.97-1.05)
100 \ 155
DISCUSSION
The analysis in a stepwise forward logistic regression model of the influence of perinatal
factors on the development of abnormal cranial ultrasound in neonates born between 24 and 34
weeks after spontaneous onset of labour with or without PROM revealed that increasing
gestational age and a full course of antenatal steroids significantly protected the neonate
against the risk of development of abnormal cranial ultrasound and that an early onset infection
significantly increased the risk. When applying this model to the surviving neonates, the
significance of gestational age disappeared (p=0.06). Antibiotics during delivery, mode of
delivery and length of assisted ventilation almost reached significance (p<0.1) (Table IV). The
incidence of severe abnormalities on cranial ultrasound in this group is 13% and coincides with
other studies 7, 8.
The protective effects of increasing gestational age and of antenatal steroid therapy have been
reported in earlier studies 3, 18, 19, 20. Although there were fewer neonates with cranial
ultrasound abnormalities when any form of antenatal steroid therapy was given, only a full
course of antenatal steroid therapy - i.e. two doses with an interval of 24 hours given at least
48 hours before birth - emerged as a significant factor in the regression analysis. This also
accords with other observations. The protective mechanism of corticosteroids may result from
an increase in neonatal blood pressure which prevents blood pressure fluctuations or may result
from an enhanced maturation of the cardiovascular system of the neonate, in addition to the
effects on the pulmonary system resulting in a decrease of the incidence in IRDS 19, 20, 21, 22.
An early onset infection (i.e. an infection that most likely already started in utero) was
significantly associated with the development of abnormal cranial ultrasound. This occurrence
has been shown in studies by Grether 23 and Spinillo 7. They found associations between early
onset infection and large intraventricular haemorrhages, periventricular leucomalacia 23 nd
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neurological impairment 7. The observation that antibiotic prophylaxis in cases of preterm
PROM protects against the development of intraventricular haemorrhage also points to a
relation between infection and cerebral damage 24, 25. The mechanism is not yet elucidated.
Leucotrins, cytokines and prostaglandins associated with the onset of preterm labour 12 may be
involved in the development of these types of cerebral damage. These substances are often
found in high concentration in membranes, amniotic fluid, placenta and umbilical cord blood in
preterm labour with spontaneous onset and play an important role in the onset of preterm birth.
These substances gain access to the fetal circulation through villi, chorion and amniotic fluid
and may alter the endothelium of the germinal matrix and damage the fetal blood-brain barrier.
This renders the neonatal brain postpartum more vulnerable to fluctuations of the blood
pressure leading to intraventricular haemorrhage and periventricular leucomalacia 12-17, 26
Clinical chorioamnionitis (an intra-amniotic infection) showed no significant relation to the
development of abnormal cranial ultrasound, although an intra-amniotic infection was
associated with early onset infection (47% versus 32%, p<0.05 chi-square). Antibiotics were
antenatally administered in 85 % of the cases having an intra-amniotic infection and this may
have had a protective effect on the development of cranial ultrasound abnormalities. In the
regression analysis, antibiotics used during labour showed a trend towards protection against
the development of intraventricular haemorrhage and periventricular leucomalacia in the
survivors (Table IV) while antibiotic administration immediately postpartum did not have an
influence on the development of ultrasound abnormalities. This may be explained by the fact
that the damaging effects of cytokines on the fetal brain already start in utero rather than after
birth.
The duration of assisted ventilation showed a trend towards the development of abnormal
cranial ultrasound in the survivors. This may reflect the severity of the illness in the neonate but
assisted ventilation is also associated with fluctuations of blood pressure in the neonatal brain
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19, 20.
The trend that a caesarean section might protect against the development of intraventricular
haemorrhage and periventricular leucomalacia accords with observations by Baud et al 27. The
found, in cases with chorioamnionitis, a lower incidence of cerebral damage in preterm
neonates born after a caesarean section compared to preterm neonates born after a vaginal
delivery. The protective mechanism of a caesarean section remains speculative, but warrants
further research.
It may be concluded from our study that three perinatal factors were found to be significantly
associated with abnormal cranial ultrasound in neonates born between 24 and 34 weeks of
gestation after spontaneous onset of labour with or without PROM; gestation age at birth, a
full course of antenatal steroid administration and early onset infection. An increasing
gestational age and a full course of antenatal steroids protected against the development of
large intraventricular haemorrhage and cystic periventricular leucomalacia; however the
occurrence of an early onset infection increased this risk.
Along with attempts to prolong gestation and the administration of steroids in cases of
spontaneous preterm birth a more liberal use of antibiotics to prevent early onset infection
might be a next step in preventing early neonatal neurological damage.
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ABSTRACT
Objective: The aim of this study was to investigate to what extend perinatal factors contribute
to the neurodevelopmental outcome in a group neonates born after spontaneous preterm
labour with or without prolonged rupture of the membranes (PROM).
Methods: Retrospectively, a group of neonates born in a tertiary referral hospital after preterm
birth between 24 and 34 weeks of pregnancy was studied. Medical records of mother and child
were analysed for antenatal and postnatal variables. At 18 months of age the
neurodevelopmental outcome was determined in the survivors by using Giffith`s developmental
quotient and by assessing cerebral palsy and major neurological disabilities. Adverse
neurodevelopmental outcome was classified as a Griffith`s score less than 85, cerebral palsy, a
major disability or perinatal death associated with severe cerebral damage. A stepwise forward
logistic regression was performed to analyse the influence of antenatal and postnatal variables
on adverse outcome.
Results: In the study period there were 8958 deliveries and 229 of these fulfilled the entry
criteria including 43 twin pregnancies. After a review of the cases 185 neonates were suitable
for analysis. Seven neonates died with severe cerebral damage. The group with an adverse
neurodevelopmental outcome had lower birth weight and gestational age at birth; received a
full course of steroid less frequently; needed a second course of antibiotics and assisted
ventilation more often and showed more cranial ultrasound abnormalities. After a forward
logistic regression analysis three factors appeared to have an independent influence: gestational
age protected against an adverse outcome (OR per day increase 0.95, 95% CI 0.90-0.97) while
abnormal cranial ultrasound (OR 6.33, 95% CI 2.16-18.52) and the need for a second course
of antibiotics (OR 1.85, 95% CI 1.02-3.33) increased the risk for adverse outcome.
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Comparing the group with a normal neurodevelopmental outcome with those with cerebral
palsy, cranial ultrasound abnormalities were independently associated with cerebral palsy (OR
48.75, 95% CI 11.78-201.76).
Conclusion: The most important way of preventing neurological damage in infants is to
increase gestational age at birth, to avoid the development of intraventricular haemorrhage and
cystic periventricular leucomalacia by administering antenatal steroids and to avoid an early
onset neonatal infection. The latter might be realised by a more aggressive use of peripartum
use of antibiotics in cases of spontaneous preterm labour with or without PROM.
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INTRODUCTION
Prematurity is the major contributor to neonatal mortality and morbidity 1, 2, 3. Long-term
neonatal morbidity is a result of the sequelae of obstetrical and neonatal events and of
neurological damage such as intraventricular haemorrhage and periventricular leucomalacia 4, 5,
6. Several studies have demonstrated that neonates born after spontaneous premature labour
with or without prolonged rupture of the membranes have an increased risk of developing
cerebral palsy or neurological impairment compared to preterm neonates born after an elective
delivery due to fetal growth restriction or maternal diseases 7, 8, 9, 10, 11.
Cytokines, leucotrins and prostaglandins originating from an inflammatory process in utero
probably play an important role in the onset of spontaneous preterm labour and are also
causally associated with neonatal neurological damage 12, 13, 14, 15, 16, 17.
In a previous study perinatal risk factors for the development of severe cranial ultrasound
abnormalities were analysed in a group of neonates born between 24 and 34 weeks after
spontaneous onset of labour with or without prolonged premature rupture of the membranes
(PROM) 18. The aim of this cohort study was to investigate to what extend perinatal factors
contribute to the neurodevelopmental outcome in this group of preterm neonates.
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MATERIALS AND METHODS
All medical records of women who delivered in the period from 1 January 1990 to 31
December 1995 at the University Hospital Utrecht, a tertiary obstetrical referral hospital in the
centre of the Netherlands were reviewed for preterm birth after spontaneous onset of labour
with or without PROM between 24 and 34 weeks of gestation. Gestational age was calculated
from the first day of the last menstrual cycle and if necessary, adjusted by early ultrasound
estimates of gestational age.
Only neonates from either singleton or twin pregnancies who were born in the University
Hospital Utrecht and were admitted to the neonatal intensive care unit (NICU) of the associ-
ated Wilhelmina’s Children’s Hospital were included in the analysis.
Those excluded from the study were: neonates that died during delivery or before admission;
neonates from higher order gestation; neonates that were intentionally delivered because of
growth retardation, maternal pregnancy induced hypertension or preeclampsia, abruptio
placentae or placenta previa; or neonates with severe congenital anomalies.
For this cohort study the maternal and neonatal medical records were searched for the
following perinatal variables:
· use of tocolytics (intravenously administered ritrodine)
· twin pregnancies
· use of antenatal corticosteroids (betamethasone) in either an incomplete or a full course
(two doses with an interval of 24 hours administered at least 48 hours antepartum)
· use of antibiotics (amoxicilline with or without clavulanic acid) before and during delivery
· duration of rupture of membranes
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· presence of an intra-amniotic infection as defined by intrapartum fever (> 37.8° C) in
combination with either fetal tachycardia, foul smelling discharge, uterine tenderness or
maternal leucocytosis (> 15,000 leucocytes / ml) 19
· mode of delivery (vaginal or caesarean section)
· gestational age at birth and birth weight
· five minute Apgar score of less than 7
· use of antibiotics immediately after birth
· early onset infection defined by sepsis (positive blood culture in a symptomatic neonate),
clinical sepsis (clinical suspicion of infection in a symptomatic neonate) and congenital
pneumonia (characteristic infiltrates noted on a chest x-ray) all within the first 48 hours of
life 19
· assisted ventilation and duration of ventilation
· results of cranial ultrasonography (normal or abnormal).
Cranial ultrasound using a UM-4 mechanical sector scanner with a rotating scan head (5-7.5-
10 MHz transducer) was performed daily on all neonates during the first week of life and twice
a week until discharge from the NICU. Ultrasound findings were considered abnormal when a
large intraventricular haemorrhage with or without unilateral parenchymal involvement (grade
III or IV according to Papile 20) or cystic periventricular leucomalacia (grade II or III
according to de Vries 21) was diagnosed upon admission to the NICU.
Neurodevelopmental outcome was classified as either normal or adverse and was used as
endpoint in both surviving and non-surviving neonates. The survivors were seen in the follow-
up clinic at 3, 9 and 18 month of age corrected for gestational age. Their neurological status
was tested by a physical examination and by Griffith`s mental development scale and items
from Amiel-Tison and Grenier and Touwen 7. Neo ates with a cerebral palsy as classified
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according to Hagberg, a major neurological disability or a developmental quotient below 85,
were considered to have an adverse neurodevelopmental outcome 7. Some neonates were seen
for follow-up by other paediatricians. Data obtained from a detailed questionnaire were used to
assess their neurodevelopmental status. Medical records of non-surviving neonates were
reviewed for the cause of death. When severe cerebral damage was diagnosed before death,
this was considered as an adverse neurodevelopmental outcome as well.
Data were analysed using the SPSS statistical software (SPSS Inc., Chicago, Illinois, USA)
and differences between categories were tested for significance using the Chi-square test and if
applicable Wilcoxon’s test or Pearson’s correlations. The contribution of the perinatal variables
on adverse neurodevelopmental outcome was analysed by a stepwise forward logistic
regression to investigate the interaction between these variables. Significance and odds ratio
(OR) with 95% confidence interval (CI) were calculated and a p-value <0.05 was considered
significant.
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RESULTS
8958 women delivered in the University Hospital Utrecht from 1-1-1990 until 31-121995. Of
these women 229 fulfilled the entry criteria (2.5%). There were 43 twin pregnancies resulting
in 272 neonates born between 24 and 34 weeks after spontaneous onset of labour with or
without PROM. For various reasons 87 neonates were excluded from the study; 60 admitted
to another NICU than the Wilhelmina’s Children Hospital, 5 stillbirths, 9 neonatal deaths due
to immaturity, 2 congenital anomalies and 11 lost to follow-up (Table I).
Table I
Study population
total number of deliveries 8958
mothers with preterm birth between 24 and 34 weeks
after spontaneous labour or prelabour rupture of membranes 229
twin pregnancies 43
total number of neonates 272
excluded because of:
· stillbirth     5
· severe congenital anomaly     2
· neonate not admitted to Wilhelmina’s Children Hospital’s NICU  60
· neonates not surviving the neonatal period due to immaturity    9
· lost to follow-up 11
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suitable for analysis including non-survivors 185
neonates not surviving the neonatal period with severe cerebral damage 7
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In 185 neonates born between 24 and 34 weeks after spontaneous onset of labour with or
without PROM all perinatal variables and results of neurodevelopmental outcome were
available for analysis. Seven neonates died in the perinatal period due to severe neurological
damage and 74 neonates were part of a twin pregnancy.
In the follow-up clinic of the Wilhelmina Children’s Hospital, 158 neonates were seen where it
was found that 50 had an adverse neurodevelopmental outcome. Local paediatricians examined
20 neonates and 4 were diagnosed as having an adverse neurodevelopmental quotient. There
were 124 neonates with a normal outcome, 14 with cerebral palsy, 7 with a major neurological
impairment (one deaf, one blind and 5 with a severe mental retardation) and 33 neonates had a
Griffith’s score of less than 85 without cerebral palsy or major impairment.
Table II shows gestational age and birth weight according to their neurodevelopmental status
and except for the group of neonates with a major neurological impairment, all groups of
neonates with an adverse outcome had a lower gestational age and a lower birth weight than
the group with a normal outcome. The group lost-to-follow-up had a significantly higher
gestational age and birth weight.
Table II
Birth weight and gestational age of the various groups
gestational age in days (sd)birth weight in grams (sd)
whole study group  n=185202 (12) 1280 (315)
normal outcome n=124 204 (11) 1340 (320)
all adverse outcome n=6196 (10) **** 1150 (260) ****
adverse outcome in survivors
n=54 196 (10) **** 1145 (260) ****
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cerebral palsy n=14 198 (9) ** 1210 (230)
major impairment n=7 202 (18) 1320 (355)
low Griffith score without
cerebral palsy and impairent
in survivors n=33 194 (7) **** 1080 (230) ****
non-survivors with cerebral
damage n=7 193 (12) * 1170 (350)
lost to follow-up n=11 214 (10) *** 1545 (285) *
* p<0.05 significance compared to group with normal outcome
** p=0.05
*** p<0.005
**** p<0.001
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In an univariate analysis, the differences in the incidence of the perinatal variables between
neonates with a normal developmental outcome and the various groups with an adverse
outcome were investigated (Table III). In the total group with an adverse neurodevelopmental
outcome the following significant differences were found when compared to the normal group:
· a lower gestational age and lower birth weight (p<0.001)
· a full course of antenatal steroids was less often given (p<0.05)
· more frequently a second antibiotic treatment was needed (p<0.001)
· more frequently and for a longer period assisted ventilation was given (p<0.001)
· more abnormal cranial ultrasound abnormalities (p<0.001).
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Table III
Perinatal variables in relation to various  neurodevelopment outcome groups
perinatal variable normal outcome adverse outcome surviving neonates cerebral palsy
n=124 n=61 with adverse outcome n=14
without cerebral
palsy or impairment
n=33
tocolysis (%) 85.5 86.9 90.9 78.6
duration of tocolysis days
 (sd) 3.6 (4.0) 3.2 (3.8) 3.4 (3.5) 3.1 (3.4)
steroids (%) 86.3 85.2 90.9 78.6
full course of steroids (%)59.3 44.3 * 51.5 35.7
antibiotics before labour (%)21 19.7 24.1 21.4
caesarean section (%) 32.3 29.5 42.4 14.3
intra-amniotic infection (%) 37.9 41 45.5 35.7
antibiotics during labour (%)50.8 37.7 45.5 21.5 *
length of ROM in hours (sd)107 (213) 117 (254) 142 (282) 27 (66)
gestational age in days (sd)204 (11) 196 (10) **** 195 (7) **** 198 (9)
birth weight in grams (sd)1340 (320) 1150 (270) **** 1080 (230) **** 1210 (230)
girls (%) 41.3 44.3 48.5 35.7
boys (%) 58.7 55.7 51.5 64.3
twin pregnancy (%) 37.9 44.3 48.5 42.9
low apgar 5 (%) 11.3 18 15.2 7.1
early onset infection (%) 45.2 39.3 27.3 57.3
antibiotics post partum (%)92.7 98.4 100 92.9
need for second antibiotic
(%) 39.8 65 **** 66.7 *** 64.3
assisted ventilation (%) 75 93.4 *** 93.9 * 92.7
length of assisted ventilation
in days (sd) 9.5 (13.5) 16.0 (16.1) *** 17.4 (15.0) **** 16.8 (22.5)
abnormal cranial ultrasound
(%) 5.6 27.9 **** 9.1 71.4 ****
Significance between various neurodevelopmental groups compared to the normal group
* p<0.05
** p<0.01
*** p<0.005
**** p<0.001
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Analysing the contribution of the perinatal variables by a stepwise forward logistic regression
analysis, gestational age at birth, need for a course of second antibiotics and severe cranial
ultrasound abnormalities revealed an independent contribution to an adverse
neurodevelopmental outcome. Gestational age (OR for increase per day 0.95, p<0.001, 95%
CI 0.90-0.97) reduced the risk while the need for a second antibiotic treatment (OR 1.85,
p<0.005, 95% CI 1.02-3.33) and the presence of severe cranial ultrasound abnormalities (OR
6.33, p<0.001, 95% CI 2.16-18.52) increased the risk. The exclusion of non-survivors in this
analysis did not change the results in the univariate or the logistic regression analysis (data not
shown).
The group with a normal outcome was also compared to the surviving neonates with a low
developmental quotient without cerebral palsy or a major neurological impairment in an
univariate analysis. Gestational age and birth weight, the need for a second antibiotic treatment
and assisted ventilation showed a significant difference but a full course of antenatal steroid
administration and abnormal cranial ultrasound no longer showed a difference. In the logistic
regression model only gestational age showed an independent statistical contribution (OR for
increase per day 0.91, p<0.001, 95% CI 0.87-0.95) to a normal outcome when compared to
the group with a low developmental quotient without cerebral palsy or a major disability.
When comparing the normal group to the surviving neonates with cerebral palsy in a univariate
analysis (Table III) two variables showed a significant difference: antibiotics during labour
(p<0.05) and cranial ultrasound abnormalities (p<0.001). In the logistic regression analysis
cranial ultrasound abnormalities emerged as the only perinatal variable with a significant
contribution to the development of cerebral palsy (OR 48.75, p<0.001, 95% CI 11.78-201.76).
Of the 21 surviving neonates with ultrasound abnormalities, 15 had an adverse
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neurodevelopmental outcome of who 10 had cerebral palsy. Only 6 neonates showed a normal
neurodevelopmental outcome (Table IV).
Table IV
Relationship between cranial ultrasound abnormalities and neurodevelopmental
outcome
survivors
total numbernon-survivorscerebral palsyadverse out-normal
come outcome
excluding
cerebral
palsy
intraventricular
haemorrhage
with venous
infarction 13 4 3 3 3
intraventricular
haemorrhage
with ventricle
dilatation 4 0 0 2 2
cystic
periventricular
leucomalacia 10 2 7 0 1
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DISCUSSION
In this study we found an incidence of adverse neurodevelopmental outcome of 32.9%. This
coincides with other studies in which the incidence varied between 17% 22 and 40% 2, 6. The
main findings of our study are that three perinatal events (gestational age, cranial ultrasound
abnormalities and the need for a second course of antibiotics) are significantly associated with
an adverse neurodevelopmental outcome in this cohort of neonates (Table III). This is partly in
accordance with other studies in which gestational age 3, 9, 22 and cranial ultrasound
abnormalities 3, 6, 9 emerged as variables significantly associated with adverse
neurodevelopmental outcome. However, in contrast to other studies, variables related to
perinatal infection such as prolonged rupture of the membranes, clinical chorioamnionitis or
neonatal early onset infection 9, 10, 11 showed no significant contribution to an adverse outcome.
The only infection-related factor in this study was the need for a second course of antibiotics in
the neonatal period.
The lack of a correlation between antenatal and early postnatal infections and the
neurodevelopmental outcome in this study may be partially be explained by an earlier study
where we demonstrated that an early onset neonatal infection was an important contributor to
cranial ultrasound abnormalities. The influence of cranial ultrasound abnormalities on
neurodevelopmental outcome is probably so apparent that in the regression analysis the
relationship with perinatal infections disappears. This may also indicate that, when these
infections do not lead to cerebral damage detectable by ultrasound, their contribution to
neurodevelopmental outcome is probably small. The independent contribution of the need for a
second course of antibiotics in the neonatal period on the neurodevelopmental outcome may be
either a reflection of the illness of the neonate or an indicator of an infectious component 4.
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A full course of antenatal steroids was less frequently administered to those neonates with an
adverse outcome, but it did not emerge as a significant contributor to the neurodevelopmental
outcome in the regression model. The reason for this lack of correlation is likely the same for
perinatal infections as discussed above. Antenatal corticosteroids administration has a
significant influence on the development of cranial ultrasound and therefore, may no longer
appear as an independent variable in the logistic regression model 11, 23.
A different picture appears when the group with an adverse neurodevelopmental outcome is
divided into a group with a low developmental quotient without cerebral palsy or neurological
impairment and a group with cerebral palsy (Table III). The only variable significantly
associated with a low developmental quotient appeared to be gestational age and in the group
with cerebral palsy only cranial ultrasound abnormalities had an independent association with
cerebral palsy. The latter observation corresponds to other studies 4, 24, 25.
When cranial ultrasound abnormalities are divided into different entities (Table IV) it reveals
that cystic periventricular leucomalacia is more frequently associated with cerebral palsy
whereas, the influence of intraventricular haemorrhage with venous infarction on the
neurodevelopmental outcome is less predictable and concurs with a study by Knoches 26.
We conclude from our data that two perinatal factors are of paramount importance with
respect to neurodevelopmental outcome in neonates born after spontaneous labour with or
without PROM between 24 and 34 weeks: gestational age and the development of cranial
ultrasound abnormalities.
The most important ways for preventing neurological damage in infants is to increase
gestational age at birth and to avoid the development of intraventricular haemorrhage and
cystic periventricular leucomalacia by administering antenatal steroids and by avoiding an early
onset neonatal infection. The latter may be realised by a more aggressive use of peripartum
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antibiotics and may be the next step in the management of cases with spontaneous preterm
labour with or without PROM 27, 28, 29.
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Chapter 8 Summary and general discussion
Preterm birth (birth before 37 completed weeks of pregnancy) is a major cause of perinatal
morbidity and mortality. Strategies to prevent and adequately treat preterm labour, in order to
postpone birth and to identify risk factors for neonatal damage due to preterm birth, have to be
developed by obstetricians and neonatologists to improve perinatal outcome. Although preterm
delivery is known to result from heterogeneous pathological conditions roughly two major
pathways lead to preterm birth:
· activation of the fetal hypothalamic-pituitary-adrenal (HPA) axis due to fetal stress or
hypoxia can lead to increase of corticotrophin releasing hormone (CRH) stimulating
prostaglandin E2 (PgE2) synthesis
· an inflammatory reaction at the chorio-decidual interface, resulting either from a
haemorrhage, trauma or microbial infection, can result in cytokine production and an
increase in PgE2 synthesis. Depending on the primary site of inflammation the initiation of
cytokine production can result in either preterm contractions with cervical softening or
rupture of membranes (ROM) with or without contractions.
The increased bioavailability of PgE2 will lead to parturition as in the term period. Various
micro-organisms found in the vaginal flora have been associated with preterm birth but no
causal relationship between a specific micro-organism and preterm birth could be established.
However in women with bacterial vaginosis, a condition where the normal lactobacilli
dominant flora is replaced by anaerobe micro-organisms a higher incidence of preterm birth is
found. The increased incidence of chorioamnionitis, early onset neonatal infectious disease and
endometritis observed in preterm birth points to a relationship between infectious aetiology and
preterm birth. This relation of infection with preterm parturition is the focus of interest in this
thesis (Chapter 1). The association of bacterial vaginosis with preterm delivery was the
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rationale for the hypothesis that antibiotics aimed against bacterial vaginosis related micro-
organisms, might reduce the incidence of preterm birth in women at high risk for preterm
delivery. In a double-blind placebo-controlled study we investigated whether clindamycin 2%
vaginal creme prophylacticly given at 26 and 32 weeks could reduce the incidence of
prematurity in a group of women, who had a preterm delivery after spontaneous onset of
labour with or without PROM in the preceding pregnancy. The placebo group consisted of 72
women, the clindamycin group of 70. Clindamycin was unable to reduce the incidence of
preterm birth when compared to the placebo group (21% preterm birth in the placebo group
versus 30% in the clindamycin group). Even an adverse effect was seen; in the clindamycin
group significantly more neonatal infectious morbidity was seen (p<.05) (Chapter 2). This is
probably caused by changes in the vaginal flora due to clindamycin treatment.
We analysed the changes in the vaginal flora during clindamycin or during placebo treatment in
the pregnant women described in Chapter 2. The alterations in type vaginal flora (normal,
intermediate or vaginosis) after clindamycin treatment or placebo were analysed using Cohen`s
kappa for similarity. There were 31 women in the clindamycin group and 33 in the placebo
group. We found a tendency towards the development of bacterial vaginosis during
clindamycin treatment in women with a normal type vaginal flora while the vaginal flora did
not change during placebo treatment (Chapter 3). The most likely explanation is that
clindamycin is bactericidal against peroxide producing lactobacilli necessary for the
maintenance of a normal flora. This effect has been demonstrated in vitro before and in vivo a
short lasting alteration of the vaginal flora with overgrowth of E.coli and Enterobacteriaceae
after treatment of bacterial vaginosis with clindamycin was observed (Chapter 3).
It is concluded from these data that antibiotic prophylaxis for prevention of preterm delivery in
a group of women with a history of preterm birth with clindamycin 2% vaginal creme is not
effective and can even increase neonatal infectious morbidity. However recent studies have
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demonstrated that antibiotic treatment of bacterial vaginosis early in the second trimester
reduces significantly the incidence of preterm birth in women with a spontaneous preterm birth
in the previous pregnancy. In these studies metronidazole was used and recently this drug has
been approved by the FDA for use during the second and third trimester of pregnancy 1.
Treatment of bacterial vaginosis early in pregnancy without additional risk factors for preterm
birth did not result in a decreased incidence of preterm delivery.
Management of preterm labour with or without PROM is generally aimed at prolongation of
the duration of pregnancy since neonatal mortality is closely related to gestational age at birth.
In cases of PROM, the threat of an intra-amniotic infection during expectant management
warrants a close supervision in order to detect infection in an early stage. We analysed the
outcome of an expectant management in 89 cases of preterm PROM between 24 and 37
weeks. The effect of this management was analysed by comparing actual survival rate at birth
with a calculated survival rate at the moment of rupture of membranes. When membranes
ruptured before 28 weeks there was a significant increase in survival rate during expectant
management when comparing actual survival rate at birth with a calculated survival rate at the
moment of rupture of membranes. In cases where membranes were ruptured for more than one
week also a beneficial prolongation of pregnancy was seen, leading to an increased survival
rate. This happened in 41 % of the cases where membranes ruptured before 34 weeks. After
this period no prolongation for more than 7 days or increase in survival was seen; however,
infectious morbidity (sepsis or sepsis-like disease) occurred in 10%. We conclude that the
neonate benefits by an expectant management in cases of PROM before 34 weeks in terms of
survival. Whether an active management of PROM after 34 weeks is justified needs to be
investigated (Chapter 4).
Diagnosing an intra-amniotic infection during expectant management of PROM between 24
and 37 weeks was done according to generally excepted criteria, being leucocytosis, fetal
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tachycardia, uterine tenderness, foul smelling discharge and fever above 37.5° C. In a group of
87 women an intra-amniotic infection was diagnosed in 43. We correlated the clinical diagnosis
with evidence of infection found postpartum; placental histology; neonatal infectious morbidity
and microbiology. The sensitivity and specificity of the ‘clinical’ diagnosis intra-amniotic
infection varied between 56% and 78% using the above mentioned infection outcome
parameters alone or combined. There was a high positive predictive value (95%) but a low
negative predictive value (30%). We conclude that although the generally used monitoring
system detects an intra-amniotic infection effectively, it does not eliminate the possible
presence of such an intra-amniotic infection when the clinical diagnosis intra-amniotic infection
is not made (Chapter 5).
Neonates born before 34 weeks after spontaneous onset of labour with or without intact
membranes have an increased risk for cranial ultrasound abnormalities such as intraventricular
haemorrhage or periventricular leucomalacia when compared to neonates born after elective
delivery due to fetal or maternal diseases. Cytokines and interleukins associated with the
spontaneous onset of preterm labour are also related with the occurrence of intraventricular
haemorrhage and periventricular leucomalacia. We investigated whether perinatal risk factors
for cranial ultrasound abnormalities could be identified in neonates born before 34 weeks after
the spontaneous onset of labour with or without PROM. We found in the study group
consisting of 205 neonates born between 24 and 34 weeks, severe cranial ultrasound
abnormalities in 27 neonates. Three perinatal risk factors could be identified; gestational age; a
full course of antenatal corticosteroids and neonatal early onset infectious disease. Increasing
gestational age at birth protected against the development of cranial ultrasound abnormalities
as well as a full course of antenatal steroids. This finding is in agreement with the literature and
is additional to the effect of steroids on lung maturation. Corticosteroids increase blood
pressure and prevent neonatal blood pressure fluctuations, which may explain the protective
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effect of corticosteroids against cranial ultrasound abnormalities. Neonatal early onset
infectious disease (infectious disease within the first 48 hours after birth) increased the risk for
neonatal cranial ultrasound abnormalities (Chapter 6). These early onset infectious diseases
already start in utero and are difficult to detect antenatally since clinical signs are not
conclusive (Chapter 5). Antibiotics given during labour for reasons of intra-amniotic infection;
as a continuation of antepartum treatment for group b streptococci colonisation or urinary tract
infection showed a trend towards protection against cranial ultrasound abnormalities in the
survivors (Chapter 6). Along with attempts to prolong gestation and the administration of
steroids in cases of spontaneous preterm birth a more liberal use of antibiotics to prevent early
onset infection might be a next step in preventing early neonatal neurological damage. Meta-
analyses of randomised studies of prophylactic use of antibiotics in cases of preterm PROM
showed that antibiotics protected against intraventricular haemorrhage in the neonate.
Antibiotic treatment also resulted in a prolonged latency period between ROM and delivery.
Whether these antibiotics act directly against causative micro-organisms or act through other
mechanisms is unclear.
In Chapter 7 the results are presented of a study where perinatal risk factors were assessed for
the neurodevelopmental outcome of the neonates born before 34 weeks after spontaneous
onset of labour with or without PROM as described in Chapter 6. In a group of 185 neonates
we found an adverse neurodevelopmental outcome in 61 (33%). An adverse
neurodevelopmental outcome was defined as a low developmental quotient, cerebral palsy, a
major neurological disability or neonatal death due to severe neurological. A forward logistic
regression analysis showed that increasing gestational age at birth protected against an adverse
outcome while neonatal ultrasound abnormalities and the need for a second antibiotic
treatment in the neonatal period increased the risk for an adverse neurodevelopmental
outcome. Neonatal cranial ultrasound abnormalities were especially associated with cerebral
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palsy when compared to those with a normal outcome. A low developmental quotient without
cerebral palsy or major neurological disability was associated with low gestational age at birth.
The most important factors in preventing neurological damage in infants is to increase
gestational age at birth and to avoid the development of intraventricular haemorrhage and
cystic periventricular leucomalacia by administering antenatal steroids and by avoiding an early
onset neonatal infection. The latter may be realised by a more aggressive use of peripartum
antibiotics and may be the next step in the management of cases with spontaneous preterm
labour with or without PROM.
Summarising the data presented in this thesis, the following conclusions are drawn:
· Prophylaxis with clindamycin 2% vaginal creme in pregnant women with a spontaneous
preterm delivery in the preceding pregnancy to prevent preterm birth does not decrease the
incidence.
· Prophylaxis with clindamycin 2% vaginal creme in pregnant women with a history
spontaneous preterm birth results in changes of the normal vaginal flora towards the
development of bacterial vaginosis
· An expectant management aimed at prolongation of the duration of pregnancy in cases
with rupture of the membranes before 34 weeks is beneficial for the fetus with respect to
mortality.
· The antenatal diagnosis of intra-amniotic infection in cases of prolonged rupture of the
membranes has a low sensitivity and specificity when compared to histological,
microbiological and neonatal signs of an intra-amniotic bacterial infection.
· Perinatal risk factors associated with severe cranial ultrasound abnormalities in the neonate
born before a gestational age of 34 weeks are gestational age at birth, antenatal
administration of corticosteroids and early onset infectious disease.
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· Perinatal factors associated with an adverse neurodevelopmental outcome in neonates born
before a gestational age of 34 weeks are gestational age, the development of severe cranial
ultrasound abnormalities and a second treatment with antibiotics in the early neonatal
period. Gestational age is mainly associated with a low developmental score while cranial
ultrasound abnormalities are mainly associated with cerebral palsy.
Recommendations for the clinician:
· Antibiotic prophylaxis or treatment is not indicated in women with a history of spontaneous
preterm birth in general but is only advised in women with such a history and who have
bacterial vaginosis in the ongoing pregnancy.
· Antibiotic prophylaxis is not (yet) indicated in cases of threatened preterm birth with intact
membranes and the results of ongoing randomised trials have to be awaited.
· Antibiotic prophylaxis in cases with rupture of the membranes before 34 weeks is advised
since it has been demonstrated that antibiotics increase the duration of pregnancy and
decrease the incidence of neonatal sepsis. Both gestational age and neonatal early onset
infection are significantly associated with the development of severe cranial ultrasound
abnormalities and neurodevelopmental outcome in the infant.
· Antibiotic prophylaxis during preterm birth is advised in cases of prolonged rupture of the
membranes before 34 weeks of gestation even in cases without clinical signs of
chorioamnionitis since in a majority an intra-amniotic infection is present. When signs of a
chorioamnionitis are present during labour antibiotic therapy is absolutely indicated.
· Antibiotic prophylaxis during preterm birth may be indicated in cases with intact membranes
especially in early gestation to prevent early onset neonatal infections
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SUMMARY IN DUTCH (Samenvatting in het Nederlands)
Inleiding
Vroeggeboorte wordt door de World Health Organisation (WHO) gedefinieerd als geboorte
voor 37 voldragen zwangerschapsweken of voor 259 dagen gerekend vanaf de eerste dag van
de laatste menstruatie. Indien er sprake is van een niet bekende eerste dag van de laatste
menstruatie of een onregelmatige cyclus kan aan het begin van de zwangerschap door
echografisch onderzoek de zwangerschapsduur worden vastgesteld. In de literatuur wordt
vroeggeboorte ook wel gedefinieerd als geboorte van een kind met een geboortegewicht onder
de 2500 gram.
Vroeggeboorte is een groot probleem in de verloskunde en in de neonatologie. De neonatale
strefte wordt voor 70-80% veroorzaakt door vroeggeboorte en 80% van alle zieke neonaten
zijn voortijdig geboren. De incidentie van vroeggeboorte bedraagt 5-10 % per jaar en is door
de jaren heen niet veranderd. De laatste jaren lijkt er een toename te zijn van vroeggeboorte.
Fertiliteits-bevorderende behandelingen en de hogere leeftijd waarop vrouwen kinderen
krijgen, zouden hiervoor een verklaring kunnen zijn.
De risicofactoren voor vroeggeboorte kunnen op basis van de ziektegeschiedenis of op basis
van socio-demografische factoren worden vastgesteld. Verder kan er gekeken worden naar een
oorzakelijk verband tussen gebeurtenissen tijdens de zwangerschap en het vroegtijdig op gang
komen van de baring. Vroeggeboorte kan veroorzaakt worden doordat de zwangerschap
eerder beëindigd moet worden vanwege problemen bij moeder of kind, maar ook kan er sprake
zijn van een voortijdige bevalling die min of meer spontaan begint, al dan niet in samenhang
met het breken van de vliezen. Deze spontane vroeggeboorte is geassocieerd met afwijkingen
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in de bacteriële samenstelling van de vrouwelijke tractus genitalis, met name met bacteriële
vaginosis waarbij de normaal aanwezige lactobacillen verdrongen zijn door andere bacteriën.
Het doel van dit proefschrift was om de volgende vragen te beantwoorden met speciale
aandacht voor de relatie tussen spontane vroeggeboorte en ontstekingen van de vrouwelijke
tractus genitalis:
· Kan vroeggeboorte voorkomen worden bij zwangeren met een verhoogd risico op spontane
vroeggeboorte door profylactische toediening van clindamycine vaginale crème?
· Hoe verandert de samenstelling van de vaginale flora in de zwangerschap door toediening
van clindamycine vaginale crème?
· Is de foetus gebaat bij een beleid gericht op uitstellen van de baring bij gebroken vliezen
voor de 37ste week van de zwangerschap?
· Hoe nauwkeurig is de klinische diagnose intra-uteriene infectie?
· Welke perinatale gebeurtenissen zijn risicofactoren voor het ontstaan van ernstig afwijkende
schedelecho`s bij vroeggeboren baby’s?
· Welke perinatale gebeurtenissen zijn risicofactoren voor het ontstaan van neurologische
schade bij te vroeg geboren kinderen?
Het eerste hoofdstuk van dit proefschrift bestaat uit een literatuuroverzicht over het op gang
komen van de baring en de relatie tussen vroeggeboorte en ontstekingen van de tractus
genitalis. De daaropvolgende hoofdstukken bestaan uit studies die de hierboven genoemde
vragen behandelen.
Het op gang komen van de baring rond de uitgerekende datum (hoofdstuk 1.1)
De uterus verkeert gedurende het grootste deel van de zwangerschap in een rustfase. Een
aantal stoffen hebben een direct relaxerend effect op de uterusspier (het myometrium). De
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belangrijkste zijn  prostacycline (PgI2) en progesteron. Daarnaast is er een mechanisme dat
stoffen, die het myometrium kunnen doen samentrekken (contraheren), afbreekt zoals het
prostaglandine-D-dehydrogenase (PGDH) dat prostaglandine E2 (PgE2) onwerkzaam maakt.
Signalen vanuit de placenta, de vliezen en de foetus doen de uterus vanuit de rustfase naar de
voorbereidingsfase (tot de baring) overgaan. Deze voorbereidingsfase wordt gekenmerkt door
het ontstaan van gap-junctions (verbindingen tussen de spiercellen van de uterus onderling).
Door deze veranderingen kan het myometrium van de uterus synchroon gaan contraheren.
Verder worden in het myometrium receptoren gecreëerd waardoor de uterus gevoeliger wordt
voor stoffen die het myometrium kunnen doen contraheren, zoals oxytocine.
Synchroon aan deze veranderingen in het myometrium vindt er verweking en ontsluiting van de
cervix plaats, essentieel voor de baring. Voor een uitgebreid overzicht over het op gang komen
van de baring wordt verwezen naar artikelen van Keelan, Challis en Mitchell (zie referentielijst
hoofdstuk 1: no. 33,35 en 39).
Absoluut noodzakelijk voor het op gang komen en doorgaan van de baring is PgE2. Aan het
eind van de zwangerschap is er een toename van de productie van PgE2 oordat er meer
enzymen, zoals phospholipase A2 (PlA2) en prostaglandine H hydrogenase (PGHS), en
bouwstenen, nodig voor de synthese van PgE2,  vrijkomen. Daarnaast is er een afname van de
activiteit van PGDH waardoor er meer PgE2  beschikbaar komt.
Corticotrophin releasing hormone (CRH) wordt door de foetus in toenemende mate
gesynthetiseerd aan het eind van de zwangerschap. Deze stijging is het gevolg van het uitrijpen
van de hypothalamic-pituitary-adrenal as (HPA-as) van de foetus. CRH stimuleert ook de
foetale bijnieren tot de productie van dehydroepiandrosteronsulfaat (DHEAS). DHEAS wordt
omgezet in oestrogenen, waardoor de verhouding tussen progesteron en oestrogeen verandert
en de remmende werking van progesteron op het myometrium afneemt.
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De concentratie in het moederlijke bloed van oxytocine neemt niet toe tijdens de baring, terwijl
bekend is dat oxytocine contracties van de uterus geeft en bij voldoende rijpheid van de cervix,
de baring in gang kan zetten. Dit komt niet omdat oxytocine in toenemende mate
geproduceerd wordt, maar omdat het myometrium gevoeliger wordt voor het aanwezige
oxytocine. Prostaglandinen spelen een rol bij deze toegenomen gevoeligheid van het
myometrium voor oxytocine.
In de cervix vindt afbraak plaats van het bindweefsel (collageen). Dit collageen is de
belangrijkste factor die er voor zorgt dat gedurende het grootste deel van de zwangerschap de
cervix gesloten blijft. Door de afbraak van collageen, wat in belangrijke mate veroorzaakt
wordt door interleukine-8 (IL8), kan de cervix verweken en door contracties van de uterus
ontsluiten.
Het voortijdig op gang komen van de baring (hoofdstuk 1.2)
Voor zover bekend zijn er twee oorzaken van belang met betrekking tot het voortijdig op gang
komen van de baring:
· vanuit de foetus kunnen signalen afgegeven worden welke uiteindelijk de
prostaglandinesynthese kunnen stimuleren. Dit kan onder meer ontstaan door
zuurstoftekort of stress van de foetus of door stress van de moeder. Deze oorzaak valt
echter niet binnen het aandachtsgebied van dit proefschrift en wordt dan ook niet
besproken.
· ten gevolge van een ontsteking dan wel irritatie op de overgang van vliezen en placenta
naar de uterus veroorzaakt door een bloeding, beschadiging of een infectie met micro-
organismen worden er stoffen (cytokines) geproduceerd waardoor de prostaglandine
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synthese op gang komt. Verder kunnen tengevolge van de ontstekingsreacties, enzymen
zoals proteases en collagenases vrijkomen, die, afhankelijk van de plek waar de ontsteking
plaatsvindt, aanleiding geven tot verweking van de cervix, leidend tot voortijdige
ontsluiting of aanleiding geven tot het breken van de vliezen.
Deze veranderingen, die tot voortijdige weeënactiviteit kunnen leiden, moeten zo heftig zijn
dat het mechanisme dat de baarmoeder in rust houdt, overwonnen wordt. Hoewel de
uiteindelijke wijze waardoor weeën ontstaan dezelfde is voor de à terme baring als voor de
voortijdige baring, namelijk activatie van de prostaglandinesynthese, is er een essentieel
verschil. Bij de à terme baring vindt er een rijping van alle weefsels plaats, leidende tot een
toegenomen prostaglandinesynthese. Bij de voortijdige baring is het óf door foetale stress óf
door een ontstekingsreactie van de decidua waardoor de prostaglandine synthese geïnitieerd
wordt. In tegenstelling tot de à terme baring, kan het op gang komen van de preterme baring
spontaan of door interventies tot stilstand komen. Dit laatste is bij à terme baring uitgesloten.
Zijn er bewijzen voor een relatie tussen ontstekingen veroorzaakt door micro-
organismen en vroeggeboorten (hoofdstuk 1.3)
De micro-organismen die bij voortijdige weeënactiviteit gevonden worden, bijvoorbeeld in het
vruchtwater of in de vliezen, zijn dezelfde micro-organismen die in de vagina gevonden
worden. Met name die micro-organismen die geassocieerd zijn met bacteriële vaginosis worden
in hoge mate teruggevonden in de baarmoederholte en zijn een risicofactor voor spontane
vroeggeboorte. Verder hebben pasgeborenen kort na een spontane vroeggeboorte vaker
infecties, die al in de baarmoeder zijn begonnen. Bij microscopisch onderzoek van de placenta
na een vroeggeboorte, wordt er in een hoog percentage tekenen van een ontstekingsreactie in
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placenta en vliezen gevonden. Moeders die voortijdig bevallen hebben vaker een ontsteking
van de baarmoeder dan de moeders die rond de uitgerekende datum bevallen.
Verder is er ook nog een omgekeerde bewijslast. Behandeling met antibiotica bij het voortijdig
breken van de vliezen, leidt tot een significant langer uitstel van de baring dan zonder deze
behandeling. Bovendien blijkt deze behandeling te leiden tot minder infecties bij de
pasgeborenen. Tevens zijn er aanwijzingen dat de antibiotische behandeling van een bacteriële
vaginosis vroeg in de zwangerschap bij vrouwen met een vroeggeboorte in de
voorgeschiedenis de herhalingskans op vroeggeboorte kan verminderen.
Uit deze gegevens blijkt duidelijk dat er een verband is tussen de bacteriële samenstelling van
de vagina, het ontstaan van infecties in de uterus en vroeggeboorte.
Studie: kan clindamycine vaginale crème, vroeg in de zwangerschap gegeven, het
vóórkomen van vroeggeboorte doen afnemen (hoofdstuk 2 en 3)
Tot nu toe hebben allerlei behandelingen om vroeggeboorte te voorkomen weinig effect gehad.
Hiertoe behoorden risicoinschatting met betrekking tot vroeggeboorte, zoals het voorschrijven
van een dieet, frequent inwendig onderzoek en het thuis opsporen van weeënactiviteit. Al deze
inspanningen hebben niet geleid tot een afname in het vóórkomen van vroeggeboorten. Tegen
de achtergrond van de relatie tussen micro-organismen in de vagina, infectie in de uterus en
vroeggeboorte, zou antibiotische profylaxe zinvol kunnen zijn. Uit onderzoek blijkt dat met
name de micro-organismen geassocieerd met bacteriële vaginosis verantwoordelijk zijn voor
het optreden van vroeggeboorte.
De vraagstelling in de studie was of antibiotica profylaxe bij een groep vrouwen met een
verhoogde kans op vroeggeboorte, het vóórkomen van vroeggeboorte zou kunnen
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verminderen. Het toegediende antibioticum zou met name gericht moeten zijn tegen micro-
organismen die geassocieerd zijn met bacteriële vaginosis. In dit onderzoek werd clindamycine
2% vaginale crème als antibioticum gebruikt. Dit middel even werkzaam is tegen bacteriële
vaginosis als metronidazol wat het standaard geneesmiddel is ter behandeling van bacteriële
vaginosis. Echter het Amerikaanse geneesmiddelenbureau (FDA) keurde ten tijde van het
onderzoek alleen clindamycine goed voor gebruik in de zwangerschap.
Om deze vraagstelling te testen is het verder noodzakelijk dit te onderzoeken bij zwangeren
met een hoog herhalingsrisico op vroeggeboorte. Daarom werd gekozen voor zwangeren die
in de voorafgaande zwangerschap een spontane vroeggeboorte al dan niet gecombineerd met
gebroken vliezen gehad hadden. In deze groep is het herhalingsrisico ongeveer 20%.
In een groep van 142 vrouwen is een dubbelblind gerandomiseerd placebo-gecontroleerd
onderzoek verricht. De placebogroep bestond uit 72 vrouwen. De behandelde groep, die
clindamycine 2% vaginale crème voorgeschreven kreeg bij 26 en 32 weken, bestond uit 70
vrouwen.
In deze groepen bleek uiteindelijk geen statistisch significant verschil te zijn in het voorkomen
van vroeggeboorten (19% vroeggeboorte in de placebogroep versus 29% in de clindamycine-
groep). Het toedienen van clindamycine bleek echter een onverwachte bijwerking te hebben; er
werden in de clindamycine-groep meer infecties bij de pasgeborene gevonden. De oorzaak
hiervan berust waarschijnlijk op veranderingen in de vaginale flora tijdens clindamycine-
gebruik. Bij de met clindamycine behandelde groep bleek er vaker een verandering in de
bacteriële samenstelling van de vagina op te treden, waarbij de normale flora van de vagina
overging naar een intermediate type flora of naar bacteriële vaginosis. Dit laatste kan worden
verklaard doordat clindamycine schadelijk is voor de lactobacillen die essentieel zijn voor een
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normale bacteriële samenstelling van de vagina. Hierdoor kan een overgroei met andere
bacteriën plaatsvinden en kan een bacteriële vaginosis ontstaan.
De conclusie uit deze studies is dat clindamycine vaginale crème niet werkzaam is om
vroeggeboorte in een groep vrouwen met een verhoogd risico op vroeggeboorte te
voorkomen. Tevens bleek dat door toediening van clindamycine 2% vaginale crème de
bacteriële samenstelling van de vagina in negatieve zin werd veranderd, waardoor de kans op
een infectie van de pasgeborene juist toenam.
Is antibiotica profylaxe nu helemaal uit den boze? Uit recent gepubliceerde studies is gebleken
dat antibiotica profylaxe alleen dan vroeggeboorte kan voorkomen indien er behalve een
bacteriële vaginosis tevens een verhoogd risico op vroeggeboorte is. Dit verhoogde risico
bestaat uit een vroeggeboorte in de vorige zwangerschap. In de studies waar dit effect
gevonden is, werd metronidazol als antibioticum gebruikt. Recent is dit geneesmiddel door de
FDA goedgekeurd voor gebruik in het tweede en derde trimester van de zwangerschap.
Resultaten van een expectatief beleid bij langdurig gebroken vliezen in de premature
periode (hoofdstuk 4 en 5)
Wanneer voor de 37ste week de vliezen breken en de baring niet op gang komt, ontstaat er een
behandelingsdilemma. Moet de bevalling zo snel mogelijk op gang worden gebracht om het
gevaar van een intra-uteriene infectie te voorkomen, of moet gepoogd worden de
zwangerschap zo lang mogelijk te laten bestaan om de kansen voor het kind te verbeteren? Dit
laatste geldt met name bij een zwangerschapsduur onder de 34 weken.
De studies in hoofdstuk 4 en 5 evalueerden de resultaten van een beleid dat erop gericht was
op enerzijds het zo lang mogelijk te laten bestaan van de zwangerschap en anderzijds om
143 \ 155
vroegtijdig op sporen van infecties. In de studiegroep waarin 89 kinderen werden geboren,
werd aan de hand van overlevingstabellen de kans op overleving op het moment van het breken
van de vliezen berekend. Deze hypothetische kans op overleving op het moment van breken
van de vliezen werd vergeleken met de werkelijke overleving. Deze werkelijke overleving werd
gezien als het resultaat van het afwachtende beleid.
Wanneer de vliezen voor de 28ste week braken, nam de werkelijke overleving significant toe ten
opzichte van de hypothetische kans op overleven op het moment van het breken van de
vliezen. Bij 25 van de 62 gevallen (41%) waarbij de vliezen voor de 34ste week braken, kon de
zwangerschap meer dan een week worden verlengd en nam de overleving daardoor significant
toe. Na de 34ste week nam de overleving niet toe tussen het moment van het breken van de
vliezen en het moment van geboorte. Wel hadden 10,7 % van de pasgeborenen een infectie. De
conclusie was dat een afwachtend beleid inderdaad resulteert in een toename van overleving
van de pasgeborene wanneer de vliezen voor 34 weken breken. Na 34 weken lijken de
voordelen van een afwachtend beleid gering met name vanwege het infectierisico (10%).
In deze studie is ook gekeken of de diagnostiek, waarmee we proberen vroegtijdig een intra-
uteriene infectie op te sporen, toereikend was. De verschijnselen die wijzen op een intra-
uteriene infectie, zijn een temperatuursverhoging bij de moeder boven de 37.5 oC, een
leucocytose, een toename van de hartfrequentie op het CTG, riekende afscheiding en een
pijnlijke uterus. Bij een combinatie van deze factoren wordt de diagnose intra-uteriene infectie
gesteld voordat de bevalling plaats heeft gevonden. In deze studie werd de diagnose die voor
de geboorte gesteld werd, vergeleken met bewijzen voor een infectie zoals die na de geboorte
gevonden kunnen worden. Dit zijn ontstekingsverschijnselen in de placenta en vliezen,
positieve bacteriële kweken van het kind en de placenta of een ziek kind.
In een groep van 87 zwangeren met gebroken vliezen voor de 37ste zwangerschapsweek werd
in 43 gevallen de diagnose intra-uteriene infectie voor de bevalling gesteld. Wanneer de
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diagnose vergeleken werd met bewijzen voor infectie die na de bevalling gevonden werden,
waren de resultaten teleurstellend. De sensitiviteit en specificiteit varieerden tussen de 50 en
70%. Wel was de positief voorspellende waarde hoog (90%). Dit houdt in dat wanneer voor
de bevalling de diagnose intra-uteriene infectie gesteld wordt, deze diagnose correct is. Echter
wanneer de diagnose niet gesteld werd, zijn er na de geboorte in een aanzienlijk percentage
aanwijzingen dat er sprake is geweest van een intra-uteriene infectie. Ten aanzien van het
beleid rond de bevalling bij vroeggeboorte en lang gebroken vliezen is dit een belangrijk
gegeven.
De uitkomst van te vroeg geboren kinderen na een spontaan begonnen baring
(hoofdstuk 6 en 7)
Kinderen geboren tussen de 24ste en 34ste week na een spontaan begonnen bevalling met of
zonder gebroken vliezen, blijken een hogere kans te hebben op cerebrale afwijkingen in de
vorm van periventriculaire leucomalacie (PVL) en intraventriculaire bloedingen (IVH) dan
kinderen die geboren worden na het kunstmatig beëindigen van de baring op foetale of
maternale indicatie. Deze afwijkingen (IVH of PVL) kunnen in de vroeg neonatale periode
vastgesteld worden met echografisch onderzoek van de schedel.
De oorzaak van deze afwijkingen kan in verband gebracht worden met stoffen die een rol
spelen bij het spontaan op gang komen van een vroeggeboorte (interleukines en
prostaglandines).
Retrospectief is bij 205 pasgeborenen die in het Academisch Ziekenhuis Utrecht tussen de 24ste
en 34ste week geboren werden na een spontaan opgang gekomen baring en vervolgens
opgenomen werden op de neonatale intensive care unit (NICU) van het WKZ, gekeken welke
factoren vlak voor en vlak na de geboorte van belang zouden kunnen zijn met betrekking tot
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het ontstaan van cerebrale afwijkingen zoals bloedingen en leucomalacie. Zestien kinderen
overleden in de eerste maand na de geboorte. De zwangerschapsduur bij de geboorte van deze
overleden kinderen was significant korter dan die van de kinderen die in leven bleven.
Cerebrale echografische afwijkingen werden bij 27 pasgeborenen gevonden.
Om de onafhankelijke invloed van de verschillende perinatale factoren vast te stellen is met een
logistische regressie-analyse onderzocht welke factoren van belang waren bij het optreden van
echografische afwijkingen. Drie factoren bleken een onafhankelijke invloed op het ontstaan van
ernstige echo-afwijkingen te hebben: zwangerschapsduur bij geboorte, een volledige
behandeling met corticosteroïden (twee giften corticosteroïden tenminste 48 uur voor de
bevalling met een interval van 24 uur gegeven) en een vroege neonatale infectie (binnen 48 na
de geboorte). Een langere zwangerschapsduur en een volledige behandeling met
corticosteroïden beschermden tegen een afwijkende schedelecho. Deze bevindingen komen
overeen met de literatuur. Corticosteroïden beschermen niet alleen tegen het respiratoir distress
syndroom bij vroeggeborenen maar verhogen de bloeddruk bij de neonaat en voorkomen
daarmee bloeddrukschommelingen wat de bescherming tegen IVH en PVL kan verklaren.
Vroege neonatale infecties bleken de kans op het ontstaan van IVH en PVL te verhogen. Deze
infecties ontstaan reeds in utero en zijn moeilijk antenataal aan te tonen (hoofdstuk 5). Hoewel
niet statistisch significant was er bij de kinderen die in leven bleven een trend waarneembaar
dat antibiotica gegeven tijdens de baring beschermden tegen cerebrale echografische
afwijkingen. Uit deze gegevens kan worden geconcludeerd dat, om de kans op cerebrale
schade bij vroeggeborenen te verminderen, het van belang is om a) te proberen de baring zo
lang mogelijk uit te stellen, b) om in elk geval corticosteroïden ruim voor de geboorte toe te
dienen en c) om neonatale infecties te vermijden. Dit laatste zou mogelijk bereikt kunnen
worden door een agressievere behandeling met antibiotica voor of tijdens de bevalling. Dit kan
ook geconcludeerd worden uit meta-analyses van gerandomiseerde studies naar het effect van
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antibiotica in gevallen van PROM voor 34 weken, waarin is aangetoond dat antibiotica
toegediend aan de moeder de neonaat beschermen tegen IVH. Ook resulteerde deze antibiotica
behandeling in een significant langere latentietijd tussen ROM en bevalling. Of antibiotica
direct effect hebben op de micro-organismen of via een ander mechanisme werken, is nog niet
duidelijk.
In dezelfde groep waarbij onderzocht is welke factoren rond de bevalling van invloed waren op
het ontstaan van cerebrale echografische afwijkingen, is gekeken naar de neurologische
ontwikkeling van het kind op langere termijn.
Van de oorspronkelijke groep van 205 neonaten die onderzocht werden op echografische
afwijkingen, zijn er 9 overleden ten gevolge van ernstige immaturiteit zonder evidente
neurologische schade en is van 11 kinderen de latere ontwikkeling onbekend. De onderzochte
groep bestond uit 185 kinderen waarvan er 7 overleden in de neonatale periode met een
ernstige cerebrale beschadiging. Een neurologisch beschadigd kind werd gedefinieerd als een
kind met een laag ontwikkelingsquotiënt, spasticiteit, een ernstige neurologische handicap of
een kind dat overleed in de neonatale periode ten gevolge van hersenbeschadiging.
Uit de logistische regressie analyse bleek dat een langere zwangerschapsduur bij geboorte
beschermde tegen neurologische schade maar dat afwijkende cerebrale echografische
bevindingen en de noodzaak om een tweede kuur met antibiotica te geven een hogere kans
gaven op neurologische schade.
Kinderen met een normale neurologische ontwikkeling zijn nog afzonderlijk vergeleken met
kinderen die spastisch waren en met kinderen met een laag ontwikkelingsquotiënt. Hieruit
bleek dat echoscopisch vastgestelde cerebrale afwijkingen met name risicofactoren waren voor
spasticiteit en dat zwangerschapsduur bij de geboorte met name geassocieerd was met een laag
ontwikkelingsquotiënt.
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Conclusies en aanbevelingen (hoofdstuk 8)
Naar aanleiding van de gegevens in dit proefschrift zijn de volgende conclusies getrokken:
· Profylaxe met clindamycine 2% vaginale crème om vroeggeboorte te voorkomen bij
zwangeren met een spontane vroeggeboorte in de voorafgaande zwangerschap vermindert
de incidentie niet. Wel is er een significante toename van neonatale infectieuze morbiditeit
bij clindamycine-gebruik.
· Profylaxe met clindamycine 2% vaginale crème bij zwangeren met een spontane
vroeggeboorte in de voorafgaande zwangerschap resulteert in een verstoring van de
normale vaginale flora en in een toename van de incidentie van bacteriële vaginosis.
· Een beleid gericht op het uitstellen van de baring in geval van gebroken vliezen voor de 34ste
week verhoogt de overlevingskans van het kind.
· De antenatale diagnose intra-uteriene infectie heeft een lage sensitiviteit en specificiteit
wanneer deze diagnose vergeleken wordt met histologische, microbiologische en neonatale
bewijzen voor een intra-uteriene infectie.
· Perinatale risicofactoren voor ernstige echografisch aantoonbare cerebrale afwijkingen bij de
pasgeborene met een zwangerschapsduur van minder dan 34 weken zijn de
zwangerschapsduur bij geboorte, een volledige behandeling met corticosteroïden voor de
geboorte en een vroeg neonatale infectie (early onset infection).
· Perinatale factoren die een rol spelen bij de neurologische ontwikkeling van de pasgeborene
met een zwangerschapsduur van minder dan 34 weken zijn zwangerschapsduur bij
geboorte, het ontstaan van IVH of PVL en een tweede behandeling met antibiotica in de
neonatale periode. Een kortere zwangerschapsduur is voornamelijk geassocieerd met een
laag ontwikkelingsquotiënt en afwijkende echografische bevindingen met spasticiteit.
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Adviezen voor de verloskundig werkzame gynaecoloog
· Antibiotische profylaxe of behandeling is niet geïndiceerd bij zwangeren met een spontane
vroeggeboorte in de voorafgaande zwangerschap. Slechts bij zwangeren met zo`n
voorgeschiedenis en met een bacteriële vaginosis in de huidige zwangerschap zijn antibiotica
geïndiceerd.
· Antibiotische profylaxe is (nog) niet zinvol bij dreigende vroeggeboorte zonder gebroken
vliezen. De resultaten van in gang zijnde grote gerandomiseerde studies moeten hierover
afgewacht worden.
· Antibiotische profylaxe bij gebroken vliezen voor de 34ste week is zinvol omdat aangetoond
is dat hierdoor het interval tussen het breken van de vliezen en de bevalling toeneemt en de
incidentie van neonatale sepsis verminderd wordt. Zowel zwangerschapsduur als neonatale
early onset infecties zijn risicofactoren voor IVH en PVL en de neurologisch ontwikkeling
op langere termijn.
· Antibiotische profylaxe tijdens een bevalling na PROM voor de 34ste week wordt
geadviseerd omdat ook bij het ontbreken van tekenen van een intra-uterien infectie in deze
gevallen vaak toch één aanwezig is.
· Antibiotische profylaxe bij een niet te remmen vroeggeboorte met staande vliezen voor de
34ste week is mogelijk - echter niet bewezen - zinvol om hiermee de kans op een infectie bij
de pasgeborene te verminderen.
· Antibiotische behandeling moet altijd voor de geboorte worden gestart bij tekenen van of
verdenking op een intra-uteriene infectie.
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LIST OF ABBREVATIONS
CI confidence interval
CRH corticotrophin releasing hormone
DHEAS dehydroepiandrosterone sulphate
FGR fetal growth restriction
HPA hypothalamic pituatary adrenal
IL-1 interleukin-1
IL-6 interleukin-6
IL-8 interleukin-8
IVH intraventricular haemorrhage
LPS lipopolysaccharide
OR odds ratio
PAF platelet activating factor
PAFAH platelet activating factor acetyl hydrolase
PGDH prostaglandin  dehydrogenase
PgE2 prostaglandin E2
PGHS prostaglandin H hydrogenase
PgI2 prostacycline
PIH pregnancy induced hypertension
PMN polymorphonuclear granulocyte
PlA2 phospholipase A2
PROM prolonged rupture of membranes
PVL periventriculair leucomalacia
ROM rupture of membranes
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TNF tumor necrosis factor
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